{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T17:12:14Z","timestamp":1788369134753,"version":"build-2803163510"},"publisher-location":"Cham","reference-count":253,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783031694905","type":"print"},{"value":"9783031694912","type":"electronic"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-3-031-69491-2_21","type":"book-chapter","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T18:17:26Z","timestamp":1732040246000},"page":"617-663","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Neuroimaging Biomarkers in Parkinson\u2019s Disease"],"prefix":"10.1007","author":[{"given":"Sophie","family":"Holmes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sule","family":"Tinaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,20]]},"reference":[{"issue":"11","key":"21_CR1","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1002\/hbm.22101","volume":"34","author":"F Agosta","year":"2013","unstructured":"Agosta F, Canu E, Stojkovi\u0107 T, Pievani M, Tomi\u0107 A, Sarro L, et al. The topography of brain damage at different stages of Parkinson\u2019s disease. Hum Brain Mapp. 2013;34(11):2798\u2013807. https:\/\/doi.org\/10.1002\/hbm.22101. Epub 2012 Apr 24. PMID: 22528144; PMCID: PMC6870174.","journal-title":"Hum Brain Mapp"},{"issue":"3","key":"21_CR2","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.nurt.2007.05.011","volume":"4","author":"AL Alexander","year":"2007","unstructured":"Alexander AL, Lee JE, Lazar M, Field AS. Diffusion tensor imaging of the brain. Neurotherapeutics. 2007;4(3):316\u201329. https:\/\/doi.org\/10.1016\/j.nurt.2007.05.011. PMID: 17599699; PMCID: PMC2041910.","journal-title":"Neurotherapeutics"},{"issue":"5","key":"21_CR3","doi-asserted-by":"publisher","first-page":"e222","DOI":"10.1016\/s2589-7500(19)30105-0","volume":"1","author":"DB Archer","year":"2019","unstructured":"Archer DB, Bricker JT, Chu WT, Burciu RG, Mccracken JL, Lai S, et al. Development and validation of the automated imaging differentiation in Parkinsonism (AID-P): a multi-site machine learning study. Lancet Digit Health. 2019;1(5):e222\u201331. https:\/\/doi.org\/10.1016\/s2589-7500(19)30105-0. Epub 2019 Aug 27. PMID: 32259098; PMCID: PMC7111208.","journal-title":"Lancet Digit Health"},{"issue":"1","key":"21_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/hbm.22622","volume":"36","author":"HC Baggio","year":"2015","unstructured":"Baggio HC, Segura B, Sala-Llonch R, Marti MJ, Valldeoriola F, Compta Y, et al. Cognitive impairment and resting-state network connectivity in Parkinson\u2019s disease. Hum Brain Mapp. 2015a;36(1):199\u2013212. https:\/\/doi.org\/10.1002\/hbm.22622. Epub 2014 Aug 28. PMID: 25164875; PMCID: PMC6869118.","journal-title":"Hum Brain Mapp"},{"issue":"5","key":"21_CR5","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/mds.26137","volume":"30","author":"HC Baggio","year":"2015","unstructured":"Baggio HC, Segura B, Garrido-Millan JL, Marti MJ, Compta Y, Valldeoriola F, et al. Resting-state frontostriatal functional connectivity in Parkinson\u2019s disease-related apathy. Mov Disord. 2015b;30(5):671\u20139. https:\/\/doi.org\/10.1002\/mds.26137. Epub 2015 Jan 20. PMID: 25600482.","journal-title":"Mov Disord"},{"key":"21_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2019.101720","volume":"22","author":"HC Baggio","year":"2019","unstructured":"Baggio HC, Abos A, Segura B, Campabadal A, Uribe C, Giraldo DM, et al. Cerebellar resting-state functional connectivity in Parkinson\u2019s disease and multiple system atrophy: characterization of abnormalities and potential for differential diagnosis at the single-patient level. Neuroimage Clin. 2019;22:101720. https:\/\/doi.org\/10.1016\/j.nicl.2019.101720. Epub 2019 Feb 13. PMID: 30785051; PMCID: PMC6383182.","journal-title":"Neuroimage Clin"},{"issue":"12","key":"21_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189897","volume":"12","author":"S Bajaj","year":"2017","unstructured":"Bajaj S, Krismer F, Palma JA, Wenning GK, Kaufmann H, Poewe W, et al. Diffusion-weighted MRI distinguishes Parkinson disease from the parkinsonian variant of multiple system atrophy: a systematic review and meta-analysis. PLoS One. 2017;12(12):e0189897. https:\/\/doi.org\/10.1371\/journal.pone.0189897. PMID: 29287113; PMCID: PMC5747439.","journal-title":"PLoS One"},{"key":"21_CR8","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.parkreldis.2021.02.027","volume":"85","author":"V Beliveau","year":"2021","unstructured":"Beliveau V, Krismer F, Skalla E, Schocke MM, Gizewski ER, Wenning GK, et al. Characterization and diagnostic potential of diffusion tractography in multiple system atrophy. Parkinsonism Relat Disord. 2021;85:30\u20136. https:\/\/doi.org\/10.1016\/j.parkreldis.2021.02.027. Epub 2021 Mar 3. PMID: 33713904.","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"21_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41531-022-00405-9","volume":"8","author":"D Ben Bashat","year":"2022","unstructured":"Ben Bashat D, Thaler A, Lerman Shacham H, Even-Sapir E, Hutchison M, Evans KC, et al. Neuromelanin and T2*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson\u2019s disease. NPJ Parkinsons Dis. 2022;8(1):139. https:\/\/doi.org\/10.1038\/s41531-022-00405-9. PMID: 36271084; PMCID: PMC9586960.","journal-title":"NPJ Parkinsons Dis."},{"key":"21_CR10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.neuropsychologia.2018.03.011","volume":"112","author":"O Bezdicek","year":"2018","unstructured":"Bezdicek O, Ballarini T, R\u016f\u017ei\u010dka F, Roth J, Mueller K, Jech R, et al. Mild cognitive impairment disrupts attention network connectivity in Parkinson\u2019s disease: a combined multimodal MRI and meta-analytical study. Neuropsychologia. 2018;112:105\u201315. https:\/\/doi.org\/10.1016\/j.neuropsychologia.2018.03.011. Epub 2018 Mar 11. PMID: 29540317.","journal-title":"Neuropsychologia"},{"issue":"9","key":"21_CR11","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1093\/brain\/awaa216","volume":"143","author":"E Biondetti","year":"2020","unstructured":"Biondetti E, Gaurav R, Yahia-Cherif L, Mangone G, Pyatigorskaya N, Valabr\u00e8gue R, et al. Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson\u2019s disease. Brain. 2020;143(9):2757\u201370. https:\/\/doi.org\/10.1093\/brain\/awaa216. Erratum in: Brain 2021, 144(2):e24. PMID: 32856056.","journal-title":"Brain"},{"issue":"10","key":"21_CR12","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1093\/brain\/awab191","volume":"144","author":"E Biondetti","year":"2021","unstructured":"Biondetti E, Santin MD, Valabr\u00e8gue R, Mangone G, Gaurav R, Pyatigorskaya N, et al. The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson\u2019s disease. Brain. 2021;144(10):3114\u201325. https:\/\/doi.org\/10.1093\/brain\/awab191. PMID: 33978742; PMCID: PMC8634084.","journal-title":"Brain"},{"issue":"4","key":"21_CR13","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/mrm.1910340409","volume":"34","author":"B Biswal","year":"1995","unstructured":"Biswal B, Yetkin FZ, Haughton VM, Hyde JS. Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magn Reson Med. 1995;34(4):537\u201341. https:\/\/doi.org\/10.1002\/mrm.1910340409. PMID: 8524021.","journal-title":"Magn Reson Med"},{"key":"21_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nicl.2016.11.004","volume":"13","author":"P Boord","year":"2016","unstructured":"Boord P, Madhyastha TM, Askren MK, Grabowski TJ. Executive attention networks show altered relationship with default mode network in PD. Neuroimage Clin. 2016;13:1\u20138. https:\/\/doi.org\/10.1016\/j.nicl.2016.11.004. PMID: 27896064; PMCID: PMC5121155.","journal-title":"Neuroimage Clin."},{"issue":"Suppl 2","key":"21_CR15","doi-asserted-by":"publisher","first-page":"II3","DOI":"10.1007\/PL00007758","volume":"247","author":"H Braak","year":"2000","unstructured":"Braak H, Braak E. Pathoanatomy of Parkinson\u2019s disease. J Neurol. 2000;247(Suppl 2):II3\u201310. https:\/\/doi.org\/10.1007\/PL00007758. PMID: 10991663.","journal-title":"J Neurol"},{"issue":"2","key":"21_CR16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging. 2003;24(2):197\u2013211. https:\/\/doi.org\/10.1016\/s0197-4580(02)00065-9. PMID: 12498954.","journal-title":"Neurobiol Aging"},{"key":"21_CR17","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.212696","volume":"16","author":"M Brammerloh","year":"2022","unstructured":"Brammerloh M, Kirilina E, Alkemade A, Bazin PL, Jantzen C, J\u00e4ger C, et al. Swallow tail sign: revisited. Radiology. 2022;16:212696. https:\/\/doi.org\/10.1148\/radiol.212696. Epub ahead of print. PMID: 35972361.","journal-title":"Radiology"},{"key":"21_CR18","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.nicl.2017.09.008","volume":"16","author":"JA Brown","year":"2017","unstructured":"Brown JA, Hua AY, Trujllo A, Attygalle S, Binney RJ, Spina S, et al. Advancing functional dysconnectivity and atrophy in progressive supranuclear palsy. Neuroimage Clin. 2017;16:564\u201374. https:\/\/doi.org\/10.1016\/j.nicl.2017.09.008. PMID: 28951832; PMCID: PMC5605489.","journal-title":"Neuroimage Clin."},{"issue":"8","key":"21_CR19","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1093\/brain\/awx146","volume":"140","author":"RG Burciu","year":"2017","unstructured":"Burciu RG, Ofori E, Archer DB, Wu SS, Pasternak O, McFarland NR, et al. Progression marker of Parkinson\u2019s disease: a 4-year multi-site imaging study. Brain. 2017;140(8):2183\u201392. https:\/\/doi.org\/10.1093\/brain\/awx146. PMID: 28899020; PMCID: PMC6057495.","journal-title":"Brain"},{"key":"21_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ejrad.2018.10.032","volume":"109","author":"SF Calloni","year":"2018","unstructured":"Calloni SF, Conte G, Sbaraini S, Cilia R, Contarino VE, Avignone S, et al. Multiparametric MR imaging of Parkinsonisms at 3 tesla: its role in the differentiation of idiopathic Parkinson\u2019s disease versus atypical Parkinsonian disorders. Eur J Radiol. 2018;109:95\u2013100. https:\/\/doi.org\/10.1016\/j.ejrad.2018.10.032. Epub 2018 Nov 1. PMID: 30527319.","journal-title":"Eur J Radiol"},{"issue":"7","key":"21_CR21","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1002\/mds.26201","volume":"30","author":"G Castellanos","year":"2015","unstructured":"Castellanos G, Fern\u00e1ndez-Seara MA, Lorenzo-Betancor O, Ortega-Cubero S, Puigvert M, Uranga J, et al. Automated neuromelanin imaging as a diagnostic biomarker for Parkinson\u2019s disease. Mov Disord. 2015;30(7):945\u201352. https:\/\/doi.org\/10.1002\/mds.26201. Epub 2015 Mar 15. PMID: 25772492.","journal-title":"Mov Disord"},{"key":"21_CR22","doi-asserted-by":"publisher","first-page":"102103","DOI":"10.1016\/j.nicl.2019.102103","volume":"25","author":"Z Cheng","year":"2020","unstructured":"Cheng Z, He N, Huang P, Li Y, Tang R, Sethi SK, et al. Imaging the Nigrosome 1 in the substantia nigra using susceptibility weighted imaging and quantitative susceptibility mapping: an application to Parkinson\u2019s disease. Neuroimage Clin. 2020;25:102103. https:\/\/doi.org\/10.1016\/j.nicl.2019.102103. Epub 2019 Nov 20. PMID: 31869769; PMCID: PMC6933220.","journal-title":"Neuroimage Clin."},{"issue":"2","key":"21_CR23","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/mds.28348","volume":"36","author":"L Chougar","year":"2021","unstructured":"Chougar L, Faouzi J, Pyatigorskaya N, Yahia-Cherif L, Gaurav R, Biondetti E, et al. Automated categorization of Parkinsonian syndromes using magnetic resonance imaging in a clinical setting. Mov Disord. 2021;36(2):460\u201370. https:\/\/doi.org\/10.1002\/mds.28348. Epub 2020 Nov 2. PMID: 33137232.","journal-title":"Mov Disord"},{"issue":"6","key":"21_CR24","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/mds.28988","volume":"37","author":"L Chougar","year":"2022","unstructured":"Chougar L, Arsovic E, Gaurav R, Biondetti E, Faucher A, Valabr\u00e8gue R, et al. Regional selectivity of neuromelanin changes in the substantia Nigra in atypical parkinsonism. Mov Disord. 2022;37(6):1245\u201355. https:\/\/doi.org\/10.1002\/mds.28988. Epub 2022 Mar 29. PMID: 35347754.","journal-title":"Mov Disord"},{"issue":"1","key":"21_CR25","doi-asserted-by":"publisher","first-page":"12164","DOI":"10.1038\/s41598-017-12457-6","volume":"7","author":"R Dan","year":"2017","unstructured":"Dan R, R\u016f\u017ei\u010dka F, Bezdicek O, R\u016f\u017ei\u010dka E, Roth J, Vymazal J, et al. Separate neural representations of depression, anxiety and apathy in Parkinson\u2019s disease. Sci Rep. 2017;7(1):12164. https:\/\/doi.org\/10.1038\/s41598-017-12457-6. PMID: 28939804; PMCID: PMC5610322.","journal-title":"Sci Rep"},{"issue":"6","key":"21_CR26","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/mds.26662","volume":"31","author":"M Delgado-Alvarado","year":"2016","unstructured":"Delgado-Alvarado M, Gago B, Navalpotro-Gomez I, Jim\u00e9nez-Urbieta H, Rodriguez-Oroz MC. Biomarkers for dementia and mild cognitive impairment in Parkinson\u2019s disease. Mov Disord. 2016;31(6):861\u201381. https:\/\/doi.org\/10.1002\/mds.26662. Epub 2016 May 19. PMID: 27193487.","journal-title":"Mov Disord"},{"issue":"Pt 4","key":"21_CR27","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1093\/brain\/114.4.1953","volume":"114","author":"DT Dexter","year":"1991","unstructured":"Dexter DT, Carayon A, Javoy-Agid F, Agid Y, Wells FR, Daniel SE, et al. Alterations in the levels of iron, ferritin and other trace metals in Parkinson\u2019s disease and other neurodegenerative diseases affecting the basal ganglia. Brain. 1991;114(Pt 4):1953\u201375. https:\/\/doi.org\/10.1093\/brain\/114.4.1953. PMID: 1832073","journal-title":"Brain"},{"issue":"1","key":"21_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/jamaneurol.2017.3299","volume":"75","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Bloem BR. The Parkinson pandemic-a call to action. JAMA Neurol. 2018;75(1):9\u201310. https:\/\/doi.org\/10.1001\/jamaneurol.2017.3299. PMID: 29131880.","journal-title":"JAMA Neurol"},{"issue":"13","key":"21_CR29","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1002\/mds.25182","volume":"27","author":"G Du","year":"2012","unstructured":"Du G, Lewis MM, Sen S, Wang J, Shaffer ML, Styner M, et al. Imaging nigral pathology and clinical progression in Parkinson\u2019s disease. Mov Disord. 2012;27(13):1636\u201343. https:\/\/doi.org\/10.1002\/mds.25182. Epub 2012 Sep 24. PMID: 23008179; PMCID: PMC3510346.","journal-title":"Mov Disord"},{"issue":"9","key":"21_CR30","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1002\/mds.27318","volume":"33","author":"G Du","year":"2018","unstructured":"Du G, Lewis MM, Sica C, He L, Connor JR, Kong L, et al. Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson\u2019s patients. Mov Disord. 2018;33(9):1423\u201331. https:\/\/doi.org\/10.1002\/mds.27318. Epub 2018 May 14. PMID: 29756399; PMCID: PMC6185755.","journal-title":"Mov Disord"},{"issue":"1","key":"21_CR31","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/ana.25376","volume":"85","author":"G Du","year":"2019","unstructured":"Du G, Lewis MM, Sica C, Kong L, Huang X. Magnetic resonance T1w\/T2w ratio: A parsimonious marker for Parkinson disease. Ann Neurol. 2019;85(1):96\u2013104. https:\/\/doi.org\/10.1002\/ana.25376. Epub 2018 Dec 19. PMID: 30408230; PMCID: PMC6342624.","journal-title":"Ann Neurol"},{"issue":"8","key":"21_CR32","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1002\/mds.29062","volume":"37","author":"G Du","year":"2022","unstructured":"Du G, Wang E, Sica C, Chen H, De Jesus S, Lewis MM, et al. Dynamics of Nigral iron accumulation in Parkinson\u2019s disease: from diagnosis to late stage. Mov Disord. 2022;37(8):1654\u201362. https:\/\/doi.org\/10.1002\/mds.29062. Epub 2022 May 25. PMID: 35614551.","journal-title":"Mov Disord"},{"issue":"Pt 4","key":"21_CR33","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/brain\/aww006","volume":"139","author":"M Ehrminger","year":"2016","unstructured":"Ehrminger M, Latimier A, Pyatigorskaya N, Garcia-Lorenzo D, Leu-Semenescu S, Vidailhet M, et al. The coeruleus\/subcoeruleus complex in idiopathic rapid eye movement sleep behaviour disorder. Brain. 2016;139(Pt 4):1180\u20138. https:\/\/doi.org\/10.1093\/brain\/aww006. Epub 2016 Feb 26. PMID: 26920675.","journal-title":"Brain"},{"issue":"7","key":"21_CR34","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1093\/brain\/awz111","volume":"142","author":"SM Fereshtehnejad","year":"2019","unstructured":"Fereshtehnejad SM, Yao C, Pelletier A, Montplaisir JY, Gagnon JF, Postuma RB. Evolution of prodromal Parkinson\u2019s disease and dementia with Lewy bodies: a prospective study. Brain. 2019;142(7):2051\u201367. https:\/\/doi.org\/10.1093\/brain\/awz111. PMID: 31111143.","journal-title":"Brain"},{"issue":"11","key":"21_CR35","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1002\/mds.28228","volume":"35","author":"M Filippi","year":"2020","unstructured":"Filippi M, Canu E, Donzuso G, Stojkovic T, Basaia S, Stankovic I, et al. Tracking cortical changes throughout cognitive decline in Parkinson\u2019s disease. Mov Disord. 2020;35(11):1987\u201398. https:\/\/doi.org\/10.1002\/mds.28228. Epub 2020 Sep 4. PMID: 32886420.","journal-title":"Mov Disord"},{"issue":"3","key":"21_CR36","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/s0896-6273(02)00569-x","volume":"33","author":"B Fischl","year":"2002","unstructured":"Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002;33(3):341\u201355. https:\/\/doi.org\/10.1016\/s0896-6273(02)00569-x. PMID: 11832223.","journal-title":"Neuron"},{"issue":"2","key":"21_CR37","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1148\/radiol.2016160274","volume":"283","author":"S Galantucci","year":"2017","unstructured":"Galantucci S, Agosta F, Stefanova E, Basaia S, van den Heuvel MP, Stojkovi\u0107 T, et al. Structural brain connectome and cognitive impairment in Parkinson disease. Radiology. 2017;283(2):515\u201325. https:\/\/doi.org\/10.1148\/radiol.2016160274. Epub 2016 Dec 7. PMID: 27924721.","journal-title":"Radiology"},{"issue":"10","key":"21_CR38","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41593-018-0237-7","volume":"21","author":"L Gan","year":"2018","unstructured":"Gan L, Cookson MR, Petrucelli L, La Spada AR. Converging pathways in neurodegeneration, from genetics to mechanisms. Nat Neurosci. 2018;21(10):1300\u20139. https:\/\/doi.org\/10.1038\/s41593-018-0237-7. Epub 2018 Sep 26. PMID: 30258237; PMCID: PMC6278826.","journal-title":"Nat Neurosci"},{"issue":"Pt 7","key":"21_CR39","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1093\/brain\/awt152","volume":"136","author":"D Garc\u00eda-Lorenzo","year":"2013","unstructured":"Garc\u00eda-Lorenzo D, Longo-Dos Santos C, Ewenczyk C, Leu-Semenescu S, Gallea C, Quattrocchi G, et al. The coeruleus\/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson\u2019s disease. Brain. 2013;136(Pt 7):2120\u20139. https:\/\/doi.org\/10.1093\/brain\/awt152. PMID: 23801736; PMCID: PMC3692035.","journal-title":"Brain"},{"issue":"7","key":"21_CR40","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1002\/mds.28531","volume":"36","author":"R Gaurav","year":"2021","unstructured":"Gaurav R, Yahia-Cherif L, Pyatigorskaya N, Mangone G, Biondetti E, Valabr\u00e8gue R, et al. Longitudinal changes in neuromelanin MRI signal in Parkinson\u2019s disease: a progression marker. Mov Disord. 2021;36(7):1592\u2013602. https:\/\/doi.org\/10.1002\/mds.28531. Epub 2021 Mar 10. PMID: 33751655; PMCID: PMC8359265.","journal-title":"Mov Disord"},{"issue":"5","key":"21_CR41","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1002\/mds.28933","volume":"37","author":"R Gaurav","year":"2022","unstructured":"Gaurav R, Pyatigorskaya N, Biondetti E, Valabr\u00e8gue R, Yahia-Cherif L, Mangone G, et al. Deep learning-based Neuromelanin MRI changes of isolated REM sleep behavior disorder. Mov Disord. 2022;37(5):1064\u20139. https:\/\/doi.org\/10.1002\/mds.28933. Epub 2022 Feb 1. PMID: 35102604; PMCID: PMC9302679.","journal-title":"Mov Disord"},{"issue":"3","key":"21_CR42","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3174\/ajnr.A5545","volume":"39","author":"T Guttuso Jr","year":"2018","unstructured":"Guttuso T Jr, Bergsland N, Hagemeier J, Lichter DG, Pasternak O, Zivadinov R. Substantia Nigra free water increases longitudinally in Parkinson disease. AJNR Am J Neuroradiol. 2018;39(3):479\u201384. https:\/\/doi.org\/10.3174\/ajnr.A5545. Epub 2018 Feb 1. PMID: 29419398; PMCID: PMC6070442.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"Pt 4","key":"21_CR43","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/brain\/awu036","volume":"137","author":"A Hanganu","year":"2014","unstructured":"Hanganu A, Bedetti C, Degroot C, Mejia-Constain B, Lafontaine AL, Soland V, et al. Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson\u2019s disease longitudinally. Brain. 2014;137(Pt 4):1120\u20139. https:\/\/doi.org\/10.1093\/brain\/awu036. Epub 2014 Mar 10. PMID: 24613932.","journal-title":"Brain"},{"issue":"10","key":"21_CR44","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1002\/mds.27802","volume":"34","author":"S Heinzel","year":"2019","unstructured":"Heinzel S, Berg D, Gasser T, Chen H, Yao C, Postuma RB. MDS task force on the definition of Parkinson\u2019s disease. Update of the MDS research criteria for prodromal Parkinson\u2019s disease. Mov Disord. 2019;34(10):1464\u201370. https:\/\/doi.org\/10.1002\/mds.27802. Epub 2019 Aug 14. PMID: 31412427.","journal-title":"Mov Disord"},{"key":"21_CR45","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.nicl.2018.03.013","volume":"18","author":"C Hohenfeld","year":"2018","unstructured":"Hohenfeld C, Werner CJ, Reetz K. Resting-state connectivity in neurodegenerative disorders: is there potential for an imaging biomarker? Neuroimage Clin. 2018;18:849\u201370. https:\/\/doi.org\/10.1016\/j.nicl.2018.03.013. PMID: 29876270; PMCID: PMC5988031.","journal-title":"Neuroimage Clin."},{"issue":"4","key":"21_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147947","volume":"11","author":"L Hopes","year":"2016","unstructured":"Hopes L, Grolez G, Moreau C, Lopes R, Ryckewaert G, Carri\u00e8re N, Auger F, Laloux C, Petrault M, Devedjian JC, Bordet R, Defebvre L, Jissendi P, Delmaire C, Devos D. Magnetic resonance imaging features of the nigrostriatal system: biomarkers of Parkinson\u2019s disease stages? PLoS One. 2016;11(4):e0147947. https:\/\/doi.org\/10.1371\/journal.pone.0147947. PMID: 27035571; PMCID: PMC4818028.","journal-title":"PLoS One"},{"issue":"10","key":"21_CR47","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1093\/brain\/awaa238","volume":"143","author":"J Horsager","year":"2020","unstructured":"Horsager J, Andersen KB, Knudsen K, Skj\u00e6rb\u00e6k C, Fedorova TD, Okkels N, et al. Brain-first versus body-first Parkinson\u2019s disease: a multimodal imaging case-control study. Brain. 2020;143(10):3077\u201388. https:\/\/doi.org\/10.1093\/brain\/awaa238. PMID: 32830221.","journal-title":"Brain"},{"key":"21_CR48","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3389\/fnagi.2016.00247","volume":"8","author":"Y Hou","year":"2016","unstructured":"Hou Y, Yang J, Luo C, Song W, Ou R, Liu W, et al. Dysfunction of the default mode network in drug-Na\u00efve Parkinson\u2019s disease with mild cognitive impairments: a resting-state fMRI study. Front Aging Neurosci. 2016;8:247. https:\/\/doi.org\/10.3389\/fnagi.2016.00247. PMID: 27833548; PMCID: PMC5080293.","journal-title":"Front Aging Neurosci"},{"issue":"6","key":"21_CR49","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU H\u00f6glinger","year":"2017","unstructured":"H\u00f6glinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, et al. Movement Disorder Society-endorsed PSP Study Group. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Mov Disord. 2017;32(6):853\u201364. https:\/\/doi.org\/10.1002\/mds.26987. Epub 2017 May 3. PMID: 28467028; PMCID: PMC5516529.","journal-title":"Mov Disord"},{"issue":"2","key":"21_CR50","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/mds.26087","volume":"30","author":"X Hu","year":"2015","unstructured":"Hu X, Song X, Yuan Y, Li E, Liu J, Liu W, et al. Abnormal functional connectivity of the amygdala is associated with depression in Parkinson\u2019s disease. Mov Disord. 2015;30(2):238\u201344. https:\/\/doi.org\/10.1002\/mds.26087. Epub 2014 Dec 27. PMID: 25545969.","journal-title":"Mov Disord"},{"key":"21_CR51","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jad.2015.05.029","volume":"183","author":"P Huang","year":"2015","unstructured":"Huang P, Xuan M, Gu Q, Yu X, Xu X, Luo W, et al. Abnormal amygdala function in Parkinson\u2019s disease patients and its relationship to depression. J Affect Disord. 2015;183:263\u20138. https:\/\/doi.org\/10.1016\/j.jad.2015.05.029. Epub 2015 May 21. PMID: 26042728.","journal-title":"J Affect Disord"},{"issue":"4","key":"21_CR52","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.9588","volume":"5","author":"I Ill\u00e1n-Gala","year":"2022","unstructured":"Ill\u00e1n-Gala I, Nigro S, VandeVrede L, Falg\u00e0s N, Heuer HW, Painous C, et al. Diagnostic accuracy of magnetic resonance imaging measures of brain atrophy across the Spectrum of progressive Supranuclear palsy and Corticobasal degeneration. JAMA Netw Open. 2022;5(4):e229588. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.9588. Erratum in: JAMA Netw Open 2022, 5(5):e2217977. PMID: 35486397; PMCID: PMC9055455.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"21_CR53","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1148\/radiol.2018172183","volume":"287","author":"GJ Ji","year":"2018","unstructured":"Ji GJ, Hu P, Liu TT, Li Y, Chen X, Zhu C, et al. Functional connectivity of the corticobasal ganglia-thalamocortical network in Parkinson disease: a systematic review and meta-analysis with cross-validation. Radiology. 2018;287(3):973\u201382. https:\/\/doi.org\/10.1148\/radiol.2018172183. Epub 2018 Mar 7. PMID: 29514016.","journal-title":"Radiology"},{"issue":"4","key":"21_CR54","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.3233\/JAD-170601","volume":"61","author":"C Kaindlstorfer","year":"2018","unstructured":"Kaindlstorfer C, Jellinger KA, Eschlb\u00f6ck S, Stefanova N, Weiss G, Wenning GK. The relevance of iron in the pathogenesis of multiple system atrophy: a viewpoint. J Alzheimers Dis. 2018;61(4):1253\u201373. https:\/\/doi.org\/10.3233\/JAD-170601. PMID: 29376857; PMCID: PMC5798525.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"21_CR55","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/mdc3.13091","volume":"8","author":"H Kathuria","year":"2020","unstructured":"Kathuria H, Mehta S, Ahuja CK, Chakravarty K, Ray S, Mittal BR, et al. Utility of imaging of nigrosome-1 on 3T MRI and its comparison with 18F-DOPA PET in the diagnosis of idiopathic Parkinson disease and atypical parkinsonism. Mov Disord Clin Pract. 2020;8(2):224\u201330. https:\/\/doi.org\/10.1002\/mdc3.13091. PMID: 33553492; PMCID: PMC7853191.","journal-title":"Mov Disord Clin Pract"},{"issue":"3","key":"21_CR56","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1007\/s00415-018-8755-5","volume":"265","author":"K Kawabata","year":"2018","unstructured":"Kawabata K, Watanabe H, Hara K, Bagarinao E, Yoneyama N, Ogura A, et al. Distinct manifestation of cognitive deficits associate with different resting-state network disruptions in non-demented patients with Parkinson\u2019s disease. J Neurol. 2018;265(3):688\u2013700. https:\/\/doi.org\/10.1007\/s00415-018-8755-5. Epub 2018 Feb 1. PMID: 29392456.","journal-title":"J Neurol"},{"issue":"3","key":"21_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151191","volume":"11","author":"H Kawaguchi","year":"2016","unstructured":"Kawaguchi H, Shimada H, Kodaka F, Suzuki M, Shinotoh H, Hirano S, et al. Principal component analysis of multimodal Neuromelanin MRI and dopamine transporter PET data provides a specific metric for the Nigral dopaminergic neuronal density. PLoS One. 2016;11(3):e0151191. https:\/\/doi.org\/10.1371\/journal.pone.0151191. PMID: 26954690; PMCID: PMC4783074.","journal-title":"PLoS One"},{"issue":"7","key":"21_CR58","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S1474-4422(18)30162-5","volume":"17","author":"K Knudsen","year":"2018","unstructured":"Knudsen K, Fedorova TD, Hansen AK, Sommerauer M, Otto M, Svendsen KB, et al. In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study. Lancet Neurol. 2018;17(7):618\u201328. https:\/\/doi.org\/10.1016\/S1474-4422(18)30162-5. Epub 2018 Jun 1. PMID: 29866443.","journal-title":"Lancet Neurol"},{"issue":"5","key":"21_CR59","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nrneurol.2011.43","volume":"7","author":"N Kouri","year":"2011","unstructured":"Kouri N, Whitwell JL, Josephs KA, Rademakers R, Dickson DW. Corticobasal degeneration: a pathologically distinct 4R tauopathy. Nat Rev Neurol. 2011;7(5):263\u201372. https:\/\/doi.org\/10.1038\/nrneurol.2011.43. Epub 2011 Apr 12. PMID: 21487420.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"21_CR60","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/mds.28281","volume":"36","author":"F Krismer","year":"2021","unstructured":"Krismer F, Beliveau V, Seppi K, Mueller C, Goebel G, Gizewski ER, et al. Automated analysis of diffusion-weighted magnetic resonance imaging for the differential diagnosis of multiple system atrophy from Parkinson\u2019s disease. Mov Disord. 2021;36(1):241\u20135. https:\/\/doi.org\/10.1002\/mds.28281. Epub 2020 Sep 16. PMID: 32935402; PMCID: PMC7891649.","journal-title":"Mov Disord"},{"issue":"6","key":"21_CR61","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/mds.27674","volume":"34","author":"S Lang","year":"2019","unstructured":"Lang S, Hanganu A, Gan LS, Kibreab M, Auclair-Ouellet N, Alrazi T, et al. Network basis of the dysexecutive and posterior cortical cognitive profiles in Parkinson\u2019s disease. Mov Disord. 2019;34(6):893\u2013902. https:\/\/doi.org\/10.1002\/mds.27674. Epub 2019 Mar 29. PMID: 30924964.","journal-title":"Mov Disord"},{"issue":"13","key":"21_CR62","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1002\/hbm.25084","volume":"41","author":"S Lang","year":"2020","unstructured":"Lang S, Ismail Z, Kibreab M, Kathol I, Sarna J, Monchi O. Common and unique connectivity at the interface of motor, neuropsychiatric, and cognitive symptoms in Parkinson\u2019s disease: a commonality analysis. Hum Brain Mapp. 2020;41(13):3749\u201364. https:\/\/doi.org\/10.1002\/hbm.25084. Epub 2020 Jun 1. PMID: 32476230; PMCID: PMC7416059.","journal-title":"Hum Brain Mapp"},{"issue":"3","key":"21_CR63","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/mds.26883","volume":"32","author":"J Langley","year":"2017","unstructured":"Langley J, Huddleston DE, Sedlacik J, Boelmans K, Hu XP. Parkinson\u2019s disease-related increase of T2*-weighted hypointensity in substantia nigra pars compacta. Mov Disord. 2017;32(3):441\u20139. https:\/\/doi.org\/10.1002\/mds.26883. Epub 2016 Dec 22. PMID: 28004859.","journal-title":"Mov Disord"},{"key":"21_CR64","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3389\/fneur.2019.00074","volume":"10","author":"JH Lee","year":"2019","unstructured":"Lee JH, Lee MS. Brain iron accumulation in atypical parkinsonian syndromes: in vivo MRI evidences for distinctive patterns. Front Neurol. 2019;10:74. https:\/\/doi.org\/10.3389\/fneur.2019.00074. PMID: 30809185; PMCID: PMC6379317.","journal-title":"Front Neurol"},{"issue":"30","key":"21_CR65","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004222","volume":"95","author":"P Liang","year":"2016","unstructured":"Liang P, Deshpande G, Zhao S, Liu J, Hu X, Li K. Altered directional connectivity between emotion network and motor network in Parkinson\u2019s disease with depression. Medicine (Baltimore). 2016;95(30):e4222. https:\/\/doi.org\/10.1097\/MD.0000000000004222. PMID: 27472694; PMCID: PMC5265831.","journal-title":"Medicine (Baltimore)"},{"issue":"13","key":"21_CR66","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1002\/mds.26321","volume":"30","author":"Y Lou","year":"2015","unstructured":"Lou Y, Huang P, Li D, Cen Z, Wang B, Gao J, et al. Altered brain network centrality in depressed Parkinson\u2019s disease patients. Mov Disord. 2015;30(13):1777\u201384. https:\/\/doi.org\/10.1002\/mds.26321. Epub 2015 Jul 16. PMID: 26180026.","journal-title":"Mov Disord"},{"issue":"8","key":"21_CR67","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1002\/hbm.22831","volume":"36","author":"C Luo","year":"2015","unstructured":"Luo C, Guo X, Song W, Chen Q, Yang J, Gong Q, et al. The trajectory of disturbed resting-state cerebral function in Parkinson\u2019s disease at different Hoehn and Yahr stages. Hum Brain Mapp. 2015;36(8):3104\u201316. https:\/\/doi.org\/10.1002\/hbm.22831. Epub 2015 May 9. PMID: 25959682; PMCID: PMC6869419.","journal-title":"Hum Brain Mapp"},{"issue":"4","key":"21_CR68","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/mds.26932","volume":"32","author":"P Mahlknecht","year":"2017","unstructured":"Mahlknecht P, Krismer F, Poewe W, Seppi K. Meta-analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson\u2019s disease. Mov Disord. 2017;32(4):619\u201323. https:\/\/doi.org\/10.1002\/mds.26932. Epub 2017 Feb 2. PMID: 28151553.","journal-title":"Mov Disord"},{"issue":"Pt 10","key":"21_CR69","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1093\/brain\/awv211","volume":"138","author":"E Mak","year":"2015","unstructured":"Mak E, Su L, Williams GB, Firbank MJ, Lawson RA, Yarnall AJ, et al. Baseline and longitudinal grey matter changes in newly diagnosed Parkinson\u2019s disease: ICICLE-PD study. Brain. 2015;138(Pt 10):2974\u201386. https:\/\/doi.org\/10.1093\/brain\/awv211. Epub 2015 Jul 14. PMID: 26173861; PMCID: PMC4671477.","journal-title":"Brain"},{"key":"21_CR70","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.neurobiolaging.2017.03.012","volume":"55","author":"E Mak","year":"2017","unstructured":"Mak E, Su L, Williams GB, Firbank MJ, Lawson RA, Yarnall AJ, et al. Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson\u2019s disease. Neurobiol Aging. 2017;55:78\u201390. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.03.012. Epub 2017 Mar 16. PMID: 28431288; PMCID: PMC5454799.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"21_CR71","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/hbm.23056","volume":"37","author":"P Manza","year":"2016","unstructured":"Manza P, Zhang S, Li CS, Leung HC. Resting-state functional connectivity of the striatum in early-stage Parkinson\u2019s disease: cognitive decline and motor symptomatology. Hum Brain Mapp. 2016;37(2):648\u201362. https:\/\/doi.org\/10.1002\/hbm.23056. Epub 2015 Nov 14. PMID: 26566885; PMCID: PMC4843498.","journal-title":"Hum Brain Mapp"},{"key":"21_CR72","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.neulet.2016.09.011","volume":"633","author":"K Matsuura","year":"2016","unstructured":"Matsuura K, Maeda M, Tabei KI, Umino M, Kajikawa H, Satoh M, et al. A longitudinal study of neuromelanin-sensitive magnetic resonance imaging in Parkinson\u2019s disease. Neurosci Lett. 2016;633:112\u20137. https:\/\/doi.org\/10.1016\/j.neulet.2016.09.011. Epub 2016 Sep 9. PMID: 27619539.","journal-title":"Neurosci Lett"},{"key":"21_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2019.101999","volume":"24","author":"S Mazzucchi","year":"2019","unstructured":"Mazzucchi S, Frosini D, Costagli M, Del Prete E, Donatelli G, Cecchi P, et al. Quantitative susceptibility mapping in atypical Parkinsonisms. Neuroimage Clin. 2019;24:101999. https:\/\/doi.org\/10.1016\/j.nicl.2019.101999. Epub 2019 Aug 31. PMID: 31539801; PMCID: PMC6812245.","journal-title":"Neuroimage Clin."},{"issue":"17","key":"21_CR74","doi-asserted-by":"publisher","first-page":"5094","DOI":"10.1002\/hbm.24760","volume":"40","author":"T Mitchell","year":"2019","unstructured":"Mitchell T, Archer DB, Chu WT, Coombes SA, Lai S, Wilkes BJ, et al. Neurite orientation dispersion and density imaging (NODDI) and free-water imaging in Parkinsonism. Hum Brain Mapp. 2019;40(17):5094\u2013107. https:\/\/doi.org\/10.1002\/hbm.24760. Epub 2019 Aug 12. PMID: 31403737; PMCID: PMC6865390.","journal-title":"Hum Brain Mapp"},{"key":"21_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2022.103022","volume":"34","author":"T Mitchell","year":"2022","unstructured":"Mitchell T, Wilkes BJ, Archer DB, Chu WT, Coombes SA, Lai S, et al. Advanced diffusion imaging to track progression in Parkinson\u2019s disease, multiple system atrophy, and progressive supranuclear palsy. Neuroimage Clin. 2022;34:103022. https:\/\/doi.org\/10.1016\/j.nicl.2022.103022. Epub 2022 Apr 26. PMID: 35489192; PMCID: PMC9062732.","journal-title":"Neuroimage Clin."},{"issue":"6","key":"21_CR76","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1007\/s00330-016-4622-x","volume":"27","author":"S Nigro","year":"2017","unstructured":"Nigro S, Arabia G, Antonini A, Weis L, Marcante A, Tessitore A, et al. Magnetic Resonance Parkinsonism Index: diagnostic accuracy of a fully automated algorithm in comparison with the manual measurement in a large Italian multicentre study in patients with progressive supranuclear palsy. Eur Radiol. 2017;27(6):2665\u201375. https:\/\/doi.org\/10.1007\/s00330-016-4622-x. Epub 2016 Oct 19. PMID: 27761709.","journal-title":"Eur Radiol"},{"issue":"6","key":"21_CR77","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/mds.28007","volume":"35","author":"S Nigro","year":"2020","unstructured":"Nigro S, Antonini A, Vaillancourt DE, Seppi K, Ceravolo R, Strafella AP, et al. Automated MRI classification in progressive Supranuclear palsy: a large international cohort study. Mov Disord. 2020;35(6):976\u201383. https:\/\/doi.org\/10.1002\/mds.28007. Epub 2020 Feb 24. PMID: 32092195; PMCID: PMC8310687.","journal-title":"Mov Disord"},{"issue":"11","key":"21_CR78","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.3174\/ajnr.A4412","volume":"36","author":"Y Noh","year":"2015","unstructured":"Noh Y, Sung YH, Lee J, Kim EY. Nigrosome 1 detection at 3T MRI for the diagnosis of early-stage idiopathic parkinson disease: assessment of diagnostic accuracy and agreement on imaging asymmetry and clinical laterality. AJNR Am J Neuroradiol. 2015;36(11):2010\u20136. https:\/\/doi.org\/10.3174\/ajnr.A4412. Epub 2015 Aug 20. PMID: 26294646; PMCID: PMC7964859.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"21_CR79","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.neurobiolaging.2014.10.029","volume":"36","author":"E Ofori","year":"2015","unstructured":"Ofori E, Pasternak O, Planetta PJ, Burciu R, Snyder A, Febo M, et al. Increased free water in the substantia nigra of Parkinson\u2019s disease: a single-site and multi-site study. Neurobiol Aging. 2015a;36(2):1097\u2013104. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.10.029. Epub 2014 Oct 31. PMID: 25467638; PMCID: PMC4315708.","journal-title":"Neurobiol Aging"},{"issue":"Pt 8","key":"21_CR80","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1093\/brain\/awv136","volume":"138","author":"E Ofori","year":"2015","unstructured":"Ofori E, Pasternak O, Planetta PJ, Li H, Burciu RG, Snyder AF, et al. Longitudinal changes in free-water within the substantia nigra of Parkinson\u2019s disease. Brain. 2015b;138(Pt 8):2322\u201331. https:\/\/doi.org\/10.1093\/brain\/awv136. Epub 2015 May 16. PMID: 25981960; PMCID: PMC4840947.","journal-title":"Brain"},{"issue":"10","key":"21_CR81","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/mds.27100","volume":"32","author":"E Ofori","year":"2017","unstructured":"Ofori E, Krismer F, Burciu RG, Pasternak O, McCracken JL, Lewis MM, et al. Free water improves detection of changes in the substantia nigra in parkinsonism: a multisite study. Mov Disord. 2017;32(10):1457\u201364. https:\/\/doi.org\/10.1002\/mds.27100. Epub 2017 Jul 17. PMID: 28714593; PMCID: PMC5718046.","journal-title":"Mov Disord"},{"issue":"9","key":"21_CR82","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s00234-015-1556-y","volume":"57","author":"M Onu","year":"2015","unstructured":"Onu M, Badea L, Roceanu A, Tivarus M, Bajenaru O. Increased connectivity between sensorimotor and attentional areas in Parkinson\u2019s disease. Neuroradiology. 2015;57(9):957\u201368. https:\/\/doi.org\/10.1007\/s00234-015-1556-y. Epub 2015 Jul 15. PMID: 26174425.","journal-title":"Neuroradiology"},{"issue":"3","key":"21_CR83","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/mrm.22055","volume":"62","author":"O Pasternak","year":"2009","unstructured":"Pasternak O, Sochen N, Gur Y, Intrator N, Assaf Y. Free water elimination and mapping from diffusion MRI. Magn Reson Med. 2009;62(3):717\u201330. https:\/\/doi.org\/10.1002\/mrm.22055. PMID: 19623619.","journal-title":"Magn Reson Med"},{"issue":"1","key":"21_CR84","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1148\/rg.2020190070","volume":"40","author":"KP Patel","year":"2020","unstructured":"Patel KP, Wymer DT, Bhatia VK, Duara R, Rajadhyaksha CD. Multimodality imaging of dementia: clinical importance and role of integrated anatomic and molecular imaging. Radiographics. 2020;40(1):200\u201322. https:\/\/doi.org\/10.1148\/rg.2020190070. PMID: 31917652; PMCID: PMC6996605.","journal-title":"Radiographics"},{"issue":"1","key":"21_CR85","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/02\/mdc3.13354","volume":"9","author":"C Peralta","year":"2021","unstructured":"Peralta C, Strafella AP, van Eimeren T, Ceravolo R, Seppi K, Kaasinen V, et al. International Parkinson Movement Disorders Society-Neuroimaging Study Group. Pragmatic Approach on Neuroimaging Techniques for the Differential Diagnosis of Parkinsonisms. Mov Disord Clin Pract. 2021;9(1):6\u201319. https:\/\/doi.org\/10.1002\/02\/mdc3.13354. PMID: 35005060; PMCID: PMC8721825.","journal-title":"Mov Disord Clin Pract"},{"issue":"4","key":"21_CR86","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/mds.27307","volume":"33","author":"P P\u00e9ran","year":"2018","unstructured":"P\u00e9ran P, Barbagallo G, Nemmi F, Sierra M, Galitzky M, Traon AP, Payoux P, Meissner WG, Rascol O. MRI supervised and unsupervised classification of Parkinson\u2019s disease and multiple system atrophy. Mov Disord. 2018;33(4):600\u20138. https:\/\/doi.org\/10.1002\/mds.27307. Epub 2018 Feb 23. PMID: 29473662.","journal-title":"Mov Disord"},{"issue":"3","key":"21_CR87","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1002\/hbm.23499","volume":"38","author":"LR Peraza","year":"2017","unstructured":"Peraza LR, Nesbitt D, Lawson RA, Duncan GW, Yarnall AJ, Khoo TK, et al. Intra- and inter-network functional alterations in Parkinson\u2019s disease with mild cognitive impairment. Hum Brain Mapp. 2017;38(3):1702\u201315. https:\/\/doi.org\/10.1002\/hbm.23499. Epub 2017 Jan 13. PMID: 28084651; PMCID: PMC6866883.","journal-title":"Hum Brain Mapp"},{"issue":"5","key":"21_CR88","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3174\/ajnr.A4229","volume":"36","author":"MC Piattella","year":"2015","unstructured":"Piattella MC, Tona F, Bologna M, Sbardella E, Formica A, Petsas N, et al. Disrupted resting-state functional connectivity in progressive supranuclear palsy. AJNR Am J Neuroradiol. 2015;36(5):915\u201321. https:\/\/doi.org\/10.3174\/ajnr.A4229. Epub 2015 Feb 5. PMID: 25655870; PMCID: PMC7990581.","journal-title":"AJNR Am J Neuroradiol"},{"key":"21_CR89","doi-asserted-by":"publisher","first-page":"8885","DOI":"10.1038\/ncomms9885","volume":"6","author":"RA Poldrack","year":"2015","unstructured":"Poldrack RA, Laumann TO, Koyejo O, Gregory B, Hover A, Chen MY, et al. Long-term neural and physiological phenotyping of a single human. Nat Commun. 2015;6:8885. https:\/\/doi.org\/10.1038\/ncomms9885. PMID: 26648521; PMCID: PMC4682164.","journal-title":"Nat Commun"},{"issue":"3","key":"21_CR90","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/brain\/awz030","volume":"142","author":"RB Postuma","year":"2019","unstructured":"Postuma RB, Iranzo A, Hu M, H\u00f6gl B, Boeve BF, Manni R, et al. Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. Brain. 2019;142(3):744\u201359. https:\/\/doi.org\/10.1093\/brain\/awz030. PMID: 30789229; PMCID: PMC6391615.","journal-title":"Brain"},{"issue":"8","key":"21_CR91","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/mds.26218","volume":"30","author":"N Pyatigorskaya","year":"2015","unstructured":"Pyatigorskaya N, Sharman M, Corvol JC, Valabregue R, Yahia-Cherif L, Poupon F, et al. High nigral iron deposition in LRRK2 and Parkin mutation carriers using R2* relaxometry. Mov Disord. 2015;30(8):1077\u201384. https:\/\/doi.org\/10.1002\/mds.26218. Epub 2015 May 22. PMID: 26011561.","journal-title":"Mov Disord"},{"key":"21_CR92","doi-asserted-by":"publisher","unstructured":"Pyatigorskaya N, Gaurav R, Arnaldi D, Leu-Semenescu S, Yahia-Cherif L, Valabregue R, et al. Magnetic resonance imaging biomarkers to assess substantia Nigra damage in idiopathic rapid eye movement sleep behavior disorder. Sleep. 2017;40(11). https:\/\/doi.org\/10.1093\/sleep\/zsx149. PMID: 28958075.","DOI":"10.1093\/sleep\/zsx149"},{"issue":"8","key":"21_CR93","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.3174\/ajnr.A5702","volume":"39","author":"N Pyatigorskaya","year":"2018","unstructured":"Pyatigorskaya N, Magnin B, Mongin M, Yahia-Cherif L, Valabregue R, Arnaldi D, et al. Comparative study of MRI biomarkers in the substantia Nigra to discriminate idiopathic Parkinson disease. AJNR Am J Neuroradiol. 2018;39(8):1460\u20137. https:\/\/doi.org\/10.3174\/ajnr.A5702. Epub 2018 Jun 28. PMID: 29954816; PMCID: PMC7410545.","journal-title":"AJNR Am J Neuroradiol"},{"key":"21_CR94","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3389\/fneur.2020.00366","volume":"11","author":"N Pyatigorskaya","year":"2020","unstructured":"Pyatigorskaya N, Sanz-Mor\u00e8re CB, Gaurav R, Biondetti E, Valabregue R, Santin M, et al. Iron imaging as a diagnostic tool for Parkinson\u2019s disease: a systematic review and meta-analysis. Front Neurol. 2020a;11:366. https:\/\/doi.org\/10.3389\/fneur.2020.00366. PMID: 32547468; PMCID: PMC7270360.","journal-title":"Front Neurol"},{"issue":"1","key":"21_CR95","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/mds.27877","volume":"35","author":"N Pyatigorskaya","year":"2020","unstructured":"Pyatigorskaya N, Yahia-Cherif L, Gaurav R, Ewenczyk C, Gallea C, Valabregue R, et al. Multimodal magnetic resonance imaging quantification of brain changes in progressive supranuclear palsy. Mov Disord. 2020b;35(1):161\u201370. https:\/\/doi.org\/10.1002\/mds.27877. Epub 2019 Nov 11. PMID: 31710146.","journal-title":"Mov Disord"},{"issue":"1","key":"21_CR96","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1148\/radiol.2453061703","volume":"246","author":"A Quattrone","year":"2008","unstructured":"Quattrone A, Nicoletti G, Messina D, Fera F, Condino F, Pugliese P, et al. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Radiology. 2008;246(1):214\u201321. https:\/\/doi.org\/10.1148\/radiol.2453061703. Epub 2007 Nov 8. PMID: 17991785.","journal-title":"Radiology"},{"key":"21_CR97","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.parkreldis.2018.07.016","volume":"54","author":"A Quattrone","year":"2018","unstructured":"Quattrone A, Morelli M, Nigro S, Quattrone A, Vescio B, Arabia G, et al. A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson\u2019s disease. Parkinsonism Relat Disord. 2018;54:3\u20138. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.07.016. Epub 2018 Jul 25. PMID: 30068492.","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"21_CR98","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/mds.28364","volume":"36","author":"A Quattrone","year":"2021","unstructured":"Quattrone A, Antonini A, Vaillancourt DE, Seppi K, Ceravolo R, Strafella AP, et al. A new MRI measure to early differentiate progressive Supranuclear palsy from de novo Parkinson\u2019s disease in clinical practice: an international study. Mov Disord. 2021;36(3):681\u20139. https:\/\/doi.org\/10.1002\/mds.28364. Epub 2020 Nov 5. PMID: 33151015; PMCID: PMC8330364.","journal-title":"Mov Disord"},{"issue":"6","key":"21_CR99","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1002\/mds.28992","volume":"37","author":"A Quattrone","year":"2022","unstructured":"Quattrone A, Bianco MG, Antonini A, Vaillancourt DE, Seppi K, Ceravolo R, et al. Development and validation of automated magnetic resonance parkinsonism index 2.0 to distinguish progressive Supranuclear palsy-parkinsonism from Parkinson\u2019s disease. Mov Disord. 2022;37(6):1272\u201381. https:\/\/doi.org\/10.1002\/mds.28992. Epub 2022 Apr 11. PMID: 35403258; PMCID: PMC9321546.","journal-title":"Mov Disord"},{"key":"21_CR100","doi-asserted-by":"publisher","first-page":"996","DOI":"10.3389\/fnins.2018.00996","volume":"12","author":"S Ren","year":"2019","unstructured":"Ren S, Zhang H, Zheng W, Liu M, Gao F, Wang Z, et al. Altered functional connectivity of Cerebello-cortical circuit in multiple system atrophy (cerebellar-type). Front Neurosci. 2019;12:996. https:\/\/doi.org\/10.3389\/fnins.2018.00996. PMID: 30662394; PMCID: PMC6328464.","journal-title":"Front Neurosci"},{"issue":"7","key":"21_CR101","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1002\/mds.27039","volume":"32","author":"J Rosskopf","year":"2017","unstructured":"Rosskopf J, Gorges M, M\u00fcller HP, Lul\u00e9 D, Uttner I, Ludolph AC, et al. Intrinsic functional connectivity alterations in progressive supranuclear palsy: differential effects in frontal cortex, motor, and midbrain networks. Mov Disord. 2017;32(7):1006\u201315. https:\/\/doi.org\/10.1002\/mds.27039. Epub 2017 May 22. PMID: 28544256.","journal-title":"Mov Disord"},{"issue":"2","key":"21_CR102","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/mds.28864","volume":"37","author":"PG Scamarcia","year":"2022","unstructured":"Scamarcia PG, Agosta F, Spinelli EG, Basaia S, Stojkovi\u0107 T, Stankovic I, et al. Longitudinal white matter damage evolution in Parkinson\u2019s disease. Mov Disord. 2022;37(2):315\u201324. https:\/\/doi.org\/10.1002\/mds.28864. Epub 2021 Nov 22. PMID: 34806799.","journal-title":"Mov Disord"},{"issue":"2","key":"21_CR103","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/ana.22245","volume":"69","author":"C Scherfler","year":"2011","unstructured":"Scherfler C, Frauscher B, Schocke M, Iranzo A, Gschliesser V, Seppi K, et al. SINBAR (Sleep Innsbruck Barcelona) Group. White and gray matter abnormalities in idiopathic rapid eye movement sleep behavior disorder: a diffusion-tensor imaging and voxel-based morphometry study. Ann Neurol. 2011;69(2):400\u20137. https:\/\/doi.org\/10.1002\/ana.22245. Epub 2010 Dec 28. PMID: 21387382.","journal-title":"Ann Neurol"},{"issue":"13","key":"21_CR104","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1212\/WNL.0000000000002518","volume":"86","author":"C Scherfler","year":"2016","unstructured":"Scherfler C, G\u00f6bel G, M\u00fcller C, Nocker M, Wenning GK, Schocke M, et al. Diagnostic potential of automated subcortical volume segmentation in atypical parkinsonism. Neurology. 2016;86(13):1242\u20139. https:\/\/doi.org\/10.1212\/WNL.0000000000002518. Epub 2016 Mar 2. PMID: 26935895.","journal-title":"Neurology"},{"key":"21_CR105","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.nicl.2013.10.006","volume":"3","author":"ST Schwarz","year":"2013","unstructured":"Schwarz ST, Abaei M, Gontu V, Morgan PS, Bajaj N, Auer DP. Diffusion tensor imaging of nigral degeneration in Parkinson\u2019s disease: a region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis. Neuroimage Clin. 2013;3:481\u20138. https:\/\/doi.org\/10.1016\/j.nicl.2013.10.006. PMID: 24273730; PMCID: PMC3830065.","journal-title":"Neuroimage Clin."},{"key":"21_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2019.101748","volume":"22","author":"S Shinde","year":"2019","unstructured":"Shinde S, Prasad S, Saboo Y, Kaushick R, Saini J, Pal PK, et al. Predictive markers for Parkinson\u2019s disease using deep neural nets on neuromelanin sensitive MRI. Neuroimage Clin. 2019;22:101748. https:\/\/doi.org\/10.1016\/j.nicl.2019.101748. Epub 2019 Mar 6. PMID: 30870733; PMCID: PMC6417260.","journal-title":"Neuroimage Clin."},{"issue":"1","key":"21_CR107","doi-asserted-by":"publisher","first-page":"6079","DOI":"10.1038\/s41598-019-42565-4","volume":"9","author":"H Sj\u00f6str\u00f6m","year":"2019","unstructured":"Sj\u00f6str\u00f6m H, Surova Y, Nilsson M, Granberg T, Westman E, van Westen D, et al. Mapping of apparent susceptibility yields promising diagnostic separation of progressive supranuclear palsy from other causes of parkinsonism. Sci Rep. 2019;9(1):6079. https:\/\/doi.org\/10.1038\/s41598-019-42565-4. PMID: 30988382; PMCID: PMC6465307.","journal-title":"Sci Rep"},{"issue":"Suppl 1","key":"21_CR108","doi-asserted-by":"publisher","first-page":"S208","DOI":"10.1016\/j.neuroimage.2004.07.051","volume":"23","author":"SM Smith","year":"2004","unstructured":"Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, et al. Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage. 2004;23(Suppl 1):S208\u201319. https:\/\/doi.org\/10.1016\/j.neuroimage.2004.07.051. PMID: 15501092.","journal-title":"NeuroImage"},{"issue":"2","key":"21_CR109","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1093\/brain\/awx348","volume":"141","author":"M Sommerauer","year":"2018","unstructured":"Sommerauer M, Fedorova TD, Hansen AK, Knudsen K, Otto M, Jeppesen J, et al. Evaluation of the noradrenergic system in Parkinson\u2019s disease: an 11C-MeNER PET and neuromelanin MRI study. Brain. 2018;141(2):496\u2013504. https:\/\/doi.org\/10.1093\/brain\/awx348. PMID: 29272343.","journal-title":"Brain"},{"issue":"3","key":"21_CR110","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1148\/radiol.2019190406","volume":"293","author":"N Spotorno","year":"2019","unstructured":"Spotorno N, Hall S, Irwin DJ, Rumetshofer T, Acosta-Cabronero J, Deik AF, et al. Diffusion tensor MRI to distinguish progressive supranuclear palsy from \u03b1-synucleinopathies. Radiology. 2019;293(3):646\u201353. https:\/\/doi.org\/10.1148\/radiol.2019190406. Epub 2019 Oct 15. PMID: 31617796; PMCID: PMC6889922.","journal-title":"Radiology"},{"issue":"12","key":"21_CR111","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1212\/WNL.0000000000002492","volume":"86","author":"NW Sterling","year":"2016","unstructured":"Sterling NW, Wang M, Zhang L, Lee EY, Du G, Lewis MM, Styner M, Huang X. Stage-dependent loss of cortical gyrification as Parkinson disease \u201cunfolds\u201d. Neurology. 2016;86(12):1143\u201351. https:\/\/doi.org\/10.1212\/WNL.0000000000002492. Epub 2016 Feb 17. PMID: 26888982; PMCID: PMC4820131.","journal-title":"Neurology"},{"key":"21_CR112","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41531-018-0047-3","volume":"4","author":"D Sulzer","year":"2018","unstructured":"Sulzer D, Cassidy C, Horga G, Kang UJ, Fahn S, Casella L, et al. Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson\u2019s disease. NPJ Parkinsons Dis. 2018;4:11. https:\/\/doi.org\/10.1038\/s41531-018-0047-3. PMID: 29644335; PMCID: PMC5893576.","journal-title":"NPJ Parkinsons Dis"},{"issue":"3","key":"21_CR113","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/mds.27929","volume":"35","author":"J Sun","year":"2020","unstructured":"Sun J, Lai Z, Ma J, Gao L, Chen M, Chen J, et al. Quantitative evaluation of iron content in idiopathic rapid eye movement sleep behavior disorder. Mov Disord. 2020;35(3):478\u201385. https:\/\/doi.org\/10.1002\/mds.27929. Epub 2019 Dec 17. PMID: 31846123.","journal-title":"Mov Disord"},{"issue":"3","key":"21_CR114","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1148\/radiol.2017162929","volume":"285","author":"X Suo","year":"2017","unstructured":"Suo X, Lei D, Li N, Cheng L, Chen F, Wang M, et al. Functional brain connectome and its relation to Hoehn and Yahr stage in Parkinson disease. Radiology. 2017;285(3):904\u201313. https:\/\/doi.org\/10.1148\/radiol.2017162929. Epub 2017 Sep 4. PMID: 28873046.","journal-title":"Radiology"},{"key":"21_CR115","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.nicl.2018.09.028","volume":"20","author":"AS Talai","year":"2018","unstructured":"Talai AS, Sedlacik J, Boelmans K, Forkert ND. Widespread diffusion changes differentiate Parkinson\u2019s disease and progressive supranuclear palsy. Neuroimage Clin. 2018;20:1037\u201343. https:\/\/doi.org\/10.1016\/j.nicl.2018.09.028. Epub 2018 Oct 4. PMID: 30342392; PMCID: PMC6197764.","journal-title":"Neuroimage Clin"},{"issue":"6","key":"21_CR116","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s11910-021-01111-4","volume":"21","author":"S Tinaz","year":"2021","unstructured":"Tinaz S. Functional connectome in Parkinson\u2019s disease and parkinsonism. Curr Neurol Neurosci Rep. 2021;21(6):24. https:\/\/doi.org\/10.1007\/s11910-021-01111-4. PMID: 33817766; PMCID: PMC8082164.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"3","key":"21_CR117","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0057904","volume":"8","author":"M Ulla","year":"2013","unstructured":"Ulla M, Bonny JM, Ouchchane L, Rieu I, Claise B, Durif F. Is R2* a new MRI biomarker for the progression of Parkinson\u2019s disease? A longitudinal follow-up. PLoS One. 2013;8(3):e57904. https:\/\/doi.org\/10.1371\/journal.pone.0057904. Epub 2013 Mar 1. PMID: 23469252; PMCID: PMC3585727.","journal-title":"PLoS One"},{"issue":"10","key":"21_CR118","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1474-4422(14)70117-6","volume":"13","author":"RJ Ward","year":"2014","unstructured":"Ward RJ, Zucca FA, Duyn JH, Crichton RR, Zecca L. The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol. 2014;13(10):1045\u201360. https:\/\/doi.org\/10.1016\/S1474-4422(14)70117-6. PMID: 25231526; PMCID: PMC5672917.","journal-title":"Lancet Neurol"},{"issue":"4","key":"21_CR119","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/jmri.25693","volume":"46","author":"Y Wang","year":"2017","unstructured":"Wang Y, Spincemaille P, Liu Z, Dimov A, Deh K, Li J, et al. Clinical quantitative susceptibility mapping (QSM): biometal imaging and its emerging roles in patient care. J Magn Reson Imaging. 2017;46(4):951\u201371. https:\/\/doi.org\/10.1002\/jmri.25693. Epub 2017 Mar 10. PMID: 28295954; PMCID: PMC5592126.","journal-title":"J Magn Reson Imaging"},{"key":"21_CR120","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.parkreldis.2018.02.019","volume":"50","author":"H Wang","year":"2018","unstructured":"Wang H, Chen H, Wu J, Tao L, Pang Y, Gu M, et al. Altered resting-state voxel-level whole-brain functional connectivity in depressed Parkinson\u2019s disease. Parkinsonism Relat Disord. 2018;50:74\u201380. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.02.019. Epub 2018 Feb 9. PMID: 29449183.","journal-title":"Parkinsonism Relat Disord"},{"key":"21_CR121","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.neuropsychologia.2018.12.019","volume":"124","author":"N Wang","year":"2019","unstructured":"Wang N, Zhang L, Yang H, Liu H, Luo X, Fan G. Similarities and differences in cerebellar grey matter volume and disrupted functional connectivity in idiopathic Parkinson\u2019s disease and multiple system atrophy. Neuropsychologia. 2019;124:125\u201332. https:\/\/doi.org\/10.1016\/j.neuropsychologia.2018.12.019. Epub 2018 Dec 24. PMID: 30590063.","journal-title":"Neuropsychologia"},{"key":"21_CR122","doi-asserted-by":"publisher","first-page":"116457","DOI":"10.1016\/j.neuroimage.2019.116457","volume":"208","author":"K Wengler","year":"2020","unstructured":"Wengler K, He X, Abi-Dargham A, Horga G. Reproducibility assessment of neuromelanin-sensitive magnetic resonance imaging protocols for region-of-interest and voxelwise analyses. Neuroimage. 2020;208:116457. https:\/\/doi.org\/10.1016\/j.neuroimage.2019.116457. Epub 2019 Dec 11. PMID: 31841683; PMCID: PMC7118586.","journal-title":"Neuroimage"},{"issue":"6","key":"21_CR123","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/mds.29005","volume":"37","author":"GK Wenning","year":"2022","unstructured":"Wenning GK, Stankovic I, Vignatelli L, Fanciulli A, Calandra-Buonaura G, Seppi K, et al. The Movement Disorder Society criteria for the diagnosis of multiple system atrophy. Mov Disord. 2022;37(6):1131\u201348. https:\/\/doi.org\/10.1002\/mds.29005. Epub 2022 Apr 21. PMID: 35445419; PMCID: PMC9321158.","journal-title":"Mov Disord"},{"issue":"3","key":"21_CR124","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1089\/brain.2012.0073","volume":"2","author":"S Whitfield-Gabrieli","year":"2012","unstructured":"Whitfield-Gabrieli S, Nieto-Castanon A. Conn: a functional connectivity toolbox for correlated and anticorrelated brain networks. Brain Connect. 2012;2(3):125\u201341. https:\/\/doi.org\/10.1089\/brain.2012.0073. Epub 2012 Jul 19. PMID: 22642651.","journal-title":"Brain Connect"},{"issue":"7","key":"21_CR125","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/mds.27038","volume":"32","author":"JL Whitwell","year":"2017","unstructured":"Whitwell JL, H\u00f6glinger GU, Antonini A, Bordelon Y, Boxer AL, Colosimo C, et al. Movement Disorder Society-endorsed PSP Study Group. Radiological biomarkers for diagnosis in PSP: where are we and where do we need to be? Mov Disord. 2017;32(7):955\u201371. https:\/\/doi.org\/10.1002\/mds.27038. Epub 2017 May 13. PMID: 28500751; PMCID: PMC5511762.","journal-title":"Mov Disord"},{"issue":"3","key":"21_CR126","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.parkreldis.2014.11.017","volume":"21","author":"M Wieler","year":"2015","unstructured":"Wieler M, Gee M, Martin WR. Longitudinal midbrain changes in early Parkinson\u2019s disease: iron content estimated from R2*\/MRI. Parkinsonism Relat Disord. 2015;21(3):179\u201383. https:\/\/doi.org\/10.1016\/j.parkreldis.2014.11.017. Epub 2014 Nov 29. PMID: 25534153.","journal-title":"Parkinsonism Relat Disord"},{"key":"21_CR127","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.parkreldis.2018.12.016","volume":"62","author":"AF Wolters","year":"2019","unstructured":"Wolters AF, van de Weijer SCF, Leentjens AFG, Duits AA, Jacobs HIL, Kuijf ML. Resting-state fMRI in Parkinson\u2019s disease patients with cognitive impairment: a meta-analysis. Parkinsonism Relat Disord. 2019;62:16\u201327. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.12.016. Epub 2018 Dec 17. PMID: 30580907.","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"21_CR128","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1002\/mds.28934","volume":"37","author":"Y Xing","year":"2022","unstructured":"Xing Y, Sapuan AH, Mart\u00edn-Bastida A, Naidu S, Tench C, Evans J, et al. Neuromelanin-MRI to quantify and track Nigral depigmentation in Parkinson\u2019s disease: a multicenter longitudinal study using template-based standardized analysis. Mov Disord. 2022;37(5):1028\u201339. https:\/\/doi.org\/10.1002\/mds.28934. Epub 2022 Feb 15. PMID: 35165920; PMCID: PMC9303322.","journal-title":"Mov Disord"},{"key":"21_CR129","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.parkreldis.2019.01.007","volume":"62","author":"J Yang","year":"2019","unstructured":"Yang J, Archer DB, Burciu RG, M\u00fcller MLTM, Roy A, Ofori E, et al. Multimodal dopaminergic and free-water imaging in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2019a;62:10\u20135. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.01.007. Epub 2019 Jan 6. PMID: 30639168; PMCID: PMC6589363.","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"21_CR130","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1007\/s11682-019-00097-5","volume":"13","author":"H Yang","year":"2019","unstructured":"Yang H, Wang N, Luo X, Lv H, Liu H, Fan G. Altered functional connectivity of dentate nucleus in parkinsonian and cerebellar variants of multiple system atrophy. Brain Imaging Behav. 2019b;13(6):1733\u201345. https:\/\/doi.org\/10.1007\/s11682-019-00097-5. PMID: 31011950.","journal-title":"Brain Imaging Behav"},{"issue":"1","key":"21_CR131","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41467-017-02416-0","volume":"9","author":"Y Yau","year":"2018","unstructured":"Yau Y, Zeighami Y, Baker TE, Larcher K, Vainik U, Dadar M, et al. Network connectivity determines cortical thinning in early Parkinson\u2019s disease progression. Nat Commun. 2018;9(1):12. https:\/\/doi.org\/10.1038\/s41467-017-02416-0. PMID: 29295991; PMCID: PMC5750227.","journal-title":"Nat Commun"},{"key":"21_CR132","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.08440","volume":"4","author":"Y Zeighami","year":"2015","unstructured":"Zeighami Y, Ulla M, Iturria-Medina Y, Dadar M, Zhang Y, Larcher KM, et al. Network structure of brain atrophy in de novo Parkinson\u2019s disease. elife. 2015;4:e08440. https:\/\/doi.org\/10.7554\/eLife.08440. PMID: 26344547; PMCID: PMC4596689.","journal-title":"elife"},{"issue":"4","key":"21_CR133","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.neuroimage.2012.03.072","volume":"61","author":"H Zhang","year":"2012","unstructured":"Zhang H, Schneider T, Wheeler-Kingshott CA, Alexander DC. NODDI: practical in vivo neurite orientation dispersion and density imaging of the human brain. NeuroImage. 2012;61(4):1000\u201316. https:\/\/doi.org\/10.1016\/j.neuroimage.2012.03.072. Epub 2012 Mar 30. PMID: 22484410.","journal-title":"NeuroImage"},{"key":"21_CR134","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.jad.2018.10.364","volume":"245","author":"H Zhang","year":"2019","unstructured":"Zhang H, Qiu Y, Luo Y, Xu P, Li Z, Zhu W, et al. The relationship of anxious and depressive symptoms in Parkinson\u2019s disease with voxel-based neuroanatomical and functional connectivity measures. J Affect Disord. 2019;245:580\u20138. https:\/\/doi.org\/10.1016\/j.jad.2018.10.364. Epub 2018 Nov 5. PMID: 30439681.","journal-title":"J Affect Disord"},{"key":"21_CR135","doi-asserted-by":"publisher","first-page":"777","DOI":"10.3389\/fnins.2019.00777","volume":"13","author":"W Zheng","year":"2019","unstructured":"Zheng W, Ren S, Zhang H, Liu M, Zhang Q, Chen Z, et al. Spatial patterns of decreased cerebral blood flow and functional connectivity in multiple system atrophy (cerebellar-type): a combined arterial spin labeling perfusion and resting state functional magnetic resonance imaging study. Front Neurosci. 2019a;13:777. https:\/\/doi.org\/10.3389\/fnins.2019.00777. PMID: 31417345; PMCID: PMC6685442.","journal-title":"Front Neurosci"},{"issue":"11","key":"21_CR136","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000495","volume":"17","author":"YQ Zheng","year":"2019","unstructured":"Zheng YQ, Zhang Y, Yau Y, Zeighami Y, Larcher K, Misic B, et al. Local vulnerability and global connectivity jointly shape neurodegenerative disease propagation. PLoS Biol. 2019b;17(11):e3000495. https:\/\/doi.org\/10.1371\/journal.pbio.3000495. PMID: 31751329; PMCID: PMC6894889.","journal-title":"PLoS Biol"},{"issue":"5","key":"21_CR137","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1093\/brain\/awab039","volume":"144","author":"L Zhou","year":"2021","unstructured":"Zhou L, Li G, Zhang Y, Zhang M, Chen Z, Zhang L, et al. Increased free water in the substantia nigra in idiopathic REM sleep behaviour disorder. Brain. 2021;144(5):1488\u201397. https:\/\/doi.org\/10.1093\/brain\/awab039. PMID: 33880500.","journal-title":"Brain"},{"issue":"9","key":"21_CR138","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1212\/wnl.55.9.1410","volume":"55","author":"RL Albin","year":"2000","unstructured":"Albin RL, Koeppe RA, Chervin RD, Consens FB, Wernette K, Frey KA, Aldrich MS. Decreased striatal dopaminergic innervation in REM sleep behavior disorder. Neurology. 2000;55(9):1410\u20132. https:\/\/doi.org\/10.1212\/wnl.55.9.1410.","journal-title":"Neurology"},{"issue":"17","key":"21_CR139","doi-asserted-by":"publisher","first-page":"4017","DOI":"10.3390\/molecules25174017","volume":"25","author":"SR Alluri","year":"2020","unstructured":"Alluri SR, Kim SW, Volkow ND, Kil K-E. PET radiotracers for CNS-adrenergic receptors: developments and perspectives. Molecules. 2020;25(17):4017.","journal-title":"Molecules"},{"issue":"8","key":"21_CR140","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1002\/mds.20897","volume":"21","author":"G Alves","year":"2006","unstructured":"Alves G, Larsen JP, Emre M, Wentzel-Larsen T, Aarsland D. Changes in motor subtype and risk for incident dementia in Parkinson\u2019s disease. Mov Disord. 2006;21(8):1123\u201330.","journal-title":"Mov Disord"},{"issue":"5","key":"21_CR141","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/mds.28984","volume":"37","author":"OM Alzghool","year":"2022","unstructured":"Alzghool OM, van Dongen G, van de Giessen E, Schoonmade L, Beaino W. \u03b1-Synuclein radiotracer development and in vivo imaging: recent advancements and new perspectives. Mov Disord. 2022;37(5):936\u201348.","journal-title":"Mov Disord"},{"issue":"9","key":"21_CR142","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1002\/mds.28617","volume":"36","author":"KB Andersen","year":"2021","unstructured":"Andersen KB, Hansen AK, Damholdt MF, Horsager J, Skj\u00e6rb\u00e6k C, Gottrup H, et al. Reduced synaptic density in patients with Lewy body dementia: an [11C] UCB-J PET imaging study. Mov Disord. 2021;36(9):2057\u201365.","journal-title":"Mov Disord"},{"key":"21_CR143","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.parkreldis.2020.05.013","volume":"75","author":"KB Andersen","year":"2020","unstructured":"Andersen KB, Hansen AK, Sommerauer M, Fedorova TD, Knudsen K, Vang K, et al. Altered sensorimotor cortex noradrenergic function in idiopathic REM sleep behaviour disorder \u2013 a PET study. Parkinsonism Relat Disord. 2020;75:63\u20139. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.05.013.","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"21_CR144","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/mds.870120107","volume":"12","author":"A Antonini","year":"1997","unstructured":"Antonini A, Schwarz J, Oertel WH, Pogarell O, Leenders KL. Long-term changes of striatal dopamine D2 receptors in patients with Parkinson\u2019s disease: a study with positron emission tomography and [11C] raclopride. Mov Disord. 1997;12(1):33\u20138.","journal-title":"Mov Disord"},{"issue":"10","key":"21_CR145","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1093\/brain\/awl162","volume":"129","author":"K Asanuma","year":"2006","unstructured":"Asanuma K, Tang C, Ma Y, Dhawan V, Mattis P, Edwards C, et al. Network modulation in the treatment of Parkinson\u2019s disease. Brain. 2006;129(10):2667\u201378.","journal-title":"Brain"},{"issue":"3","key":"21_CR146","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1468-1331.2009.02900.x","volume":"17","author":"P Barone","year":"2010","unstructured":"Barone P. Neurotransmission in Parkinson\u2019s disease: beyond dopamine. Eur J Neurol. 2010;17(3):364\u201376. https:\/\/doi.org\/10.1111\/j.1468-1331.2009.02900.x.","journal-title":"Eur J Neurol"},{"issue":"4","key":"21_CR147","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","volume":"20","author":"H Bernheimer","year":"1973","unstructured":"Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington clinical, morphological and neurochemical correlations. J Neurol Sci. 1973;20(4):415\u201355.","journal-title":"J Neurol Sci"},{"issue":"20","key":"21_CR148","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1212\/WNL.0b013e3181c1ded6","volume":"73","author":"N Bohnen","year":"2009","unstructured":"Bohnen N, M\u00fcller M, Koeppe R, Studenski S, Kilbourn M, Frey K, Albin R. History of falls in Parkinson disease is associated with reduced cholinergic activity. Neurology. 2009;73(20):1670\u20136.","journal-title":"Neurology"},{"issue":"9","key":"21_CR149","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/sj.jcbfm.9600276","volume":"26","author":"NI Bohnen","year":"2006","unstructured":"Bohnen NI, Albm RL, Koeppe RA, Wernette KA, Kilbourn MR, Minoshima S, Frey KA. Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease. J Cereb Blood Flow Metab. 2006;26(9):1198\u2013212.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"9","key":"21_CR150","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1002\/mds.25929","volume":"29","author":"NI Bohnen","year":"2014","unstructured":"Bohnen NI, Frey KA, Studenski S, Kotagal V, Koeppe RA, Constantine GM, et al. Extra-nigral pathological conditions are common in Parkinson\u2019s disease with freezing of gait: an in vivo positron emission tomography study. Mov Disord. 2014;29(9):1118\u201324.","journal-title":"Mov Disord"},{"key":"21_CR151","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/bs.irn.2018.07.027","volume":"141","author":"NI Bohnen","year":"2018","unstructured":"Bohnen NI, Kanel P, M\u00fcller M. Molecular imaging of the cholinergic system in Parkinson\u2019s disease. Int Rev Neurobiol. 2018;141:211\u201350. https:\/\/doi.org\/10.1016\/bs.irn.2018.07.027.","journal-title":"Int Rev Neurobiol"},{"issue":"12","key":"21_CR152","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1001\/archneur.60.12.1745","volume":"60","author":"NI Bohnen","year":"2003","unstructured":"Bohnen NI, Kaufer DI, Ivanco LS, Lopresti B, Koeppe RA, Davis JG, et al. Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. Arch Neurol. 2003;60(12):1745\u20138.","journal-title":"Arch Neurol"},{"issue":"4","key":"21_CR153","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S1474-4422(21)00377-X","volume":"21","author":"NI Bohnen","year":"2022","unstructured":"Bohnen NI, Yarnall AJ, Weil RS, Moro E, Moehle MS, Borghammer P, et al. Cholinergic system changes in Parkinson\u2019s disease: emerging therapeutic approaches. The Lancet Neurology. 2022;21(4):381\u201392. https:\/\/doi.org\/10.1016\/S1474-4422(21)00377-X.","journal-title":"The Lancet Neurology"},{"issue":"5","key":"21_CR154","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1093\/brain\/awn337","volume":"132","author":"I Boileau","year":"2009","unstructured":"Boileau I, Guttman M, Rusjan P, Adams JR, Houle S, Tong J, et al. Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson\u2019s disease. Brain. 2009;132(5):1366\u201375.","journal-title":"Brain"},{"issue":"12","key":"21_CR155","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1002\/mds.22212","volume":"23","author":"I Boileau","year":"2008","unstructured":"Boileau I, Warsh JJ, Guttman M, Saint-Cyr JA, McCluskey T, Rusjan P, et al. Elevated serotonin transporter binding in depressed patients with Parkinson\u2019s disease: a preliminary PET study with [11C]DASB. Mov Disord. 2008;23(12):1776\u201380. https:\/\/doi.org\/10.1002\/mds.22212.","journal-title":"Mov Disord"},{"issue":"2","key":"21_CR156","doi-asserted-by":"publisher","first-page":"II3-II10","DOI":"10.1007\/PL00007758","volume":"247","author":"H Braak","year":"2000","unstructured":"Braak H, Braak E. Pathoanatomy of Parkinson\u2019s disease. J Neurol. 2000;247(2):II3-II10. https:\/\/doi.org\/10.1007\/PL00007758.","journal-title":"J Neurol"},{"issue":"2","key":"21_CR157","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, De Vos RA, Steur ENJ, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging. 2003;24(2):197\u2013211.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"21_CR158","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.pneurobio.2011.08.009","volume":"95","author":"DJ Brooks","year":"2011","unstructured":"Brooks DJ, Pavese N. Imaging biomarkers in Parkinson\u2019s disease. Prog Neurobiol. 2011;95(4):614\u201328. https:\/\/doi.org\/10.1016\/j.pneurobio.2011.08.009.","journal-title":"Prog Neurobiol"},{"issue":"7","key":"21_CR159","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/mds.22484","volume":"24","author":"A Br\u00fcck","year":"2009","unstructured":"Br\u00fcck A, Aalto S, Rauhala E, Bergman J, Marttila R, Rinne JO. A follow-up study on 6-[18F]fluoro-L-dopa uptake in early Parkinson\u2019s disease shows nonlinear progression in the putamen. Mov Disord. 2009;24(7):1009\u201315. https:\/\/doi.org\/10.1002\/mds.22484.","journal-title":"Mov Disord"},{"issue":"2","key":"21_CR160","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s12149-018-1305-5","volume":"33","author":"J Brumberg","year":"2019","unstructured":"Brumberg J, Tran-Gia J, Lapa C, Isaias IU, Samnick S. PET imaging of noradrenaline transporters in Parkinson\u2019s disease: focus on scan time. Ann Nucl Med. 2019;33(2):69\u201377. https:\/\/doi.org\/10.1007\/s12149-018-1305-5.","journal-title":"Ann Nucl Med"},{"issue":"supplement 1","key":"21_CR161","first-page":"1120","volume":"62","author":"R Carson","year":"2021","unstructured":"Carson R, Berg E, Badawi R, Cherry S, Du J, Feng T, et al. Design of the NeuroEXPLORER, a next-generation ultra-high performance human brain PET imager. J Nucl Med. 2021;62(supplement 1):1120.","journal-title":"J Nucl Med"},{"issue":"7","key":"21_CR162","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1093\/brain\/awm082","volume":"130","author":"M Carta","year":"2007","unstructured":"Carta M, Carlsson T, Kirik D, Bj\u00f6rklund A. Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats. Brain. 2007;130(7):1819\u201333.","journal-title":"Brain"},{"issue":"3","key":"21_CR163","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","volume":"5","author":"KR Chaudhuri","year":"2006","unstructured":"Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management. Lancet Neurol. 2006;5(3):235\u201345.","journal-title":"Lancet Neurol"},{"key":"21_CR164","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.3389\/fimmu.2018.02122","volume":"9","author":"X Chen","year":"2018","unstructured":"Chen X, Hu Y, Cao Z, Liu Q, Cheng Y. Cerebrospinal fluid inflammatory cytokine aberrations in Alzheimer\u2019s disease, Parkinson\u2019s disease and amyotrophic lateral sclerosis: a systematic review and meta-analysis. Front Immunol. 2018;9:2122.","journal-title":"Front Immunol"},{"issue":"8","key":"21_CR165","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1002\/mds.28564","volume":"36","author":"SJ Colloby","year":"2021","unstructured":"Colloby SJ, Nathan PJ, Bakker G, Lawson RA, Yarnall AJ, Burn DJ, et al. Spatial covariance of cholinergic muscarinic M1\/M4 receptors in Parkinson\u2019s disease. Mov Disord. 2021;36(8):1879\u201388.","journal-title":"Mov Disord"},{"issue":"4","key":"21_CR166","first-page":"355","volume":"58","author":"J Darcourt","year":"2014","unstructured":"Darcourt J, Schiazza A, Sapin N, Dufour M, Ouvrier MJ, Benisvy D, et al. 18F-FDOPA PET for the diagnosis of parkinsonian syndromes. Q J Nucl Med Mol Imaging. 2014;58(4):355\u201365.","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"9","key":"21_CR167","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1002\/mds.29148","volume":"37","author":"A Delva","year":"2022","unstructured":"Delva A, Van Laere K, Vandenberghe W. Longitudinal positron emission tomography imaging of presynaptic terminals in early Parkinson\u2019s disease. Mov Disord. 2022;37(9):1883\u201392.","journal-title":"Mov Disord"},{"issue":"11","key":"21_CR168","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1002\/mds.28216","volume":"35","author":"A Delva","year":"2020","unstructured":"Delva A, Van Weehaeghe D, Koole M, Van Laere K, Vandenberghe W. Loss of presynaptic terminal integrity in the substantia nigra in early Parkinson\u2019s disease. Mov Disord. 2020;35(11):1977\u201386.","journal-title":"Mov Disord"},{"issue":"19","key":"21_CR169","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.3390\/cells11193081","volume":"11","author":"RK Doot","year":"2022","unstructured":"Doot RK, Young AJ, Nasrallah IM, Wetherill RR, Siderowf A, Mach RH, Dubroff JG. [18F]NOS PET brain imaging suggests elevated neuroinflammation in idiopathic Parkinson\u2019s disease. Cells. 2022;11(19):3081.","journal-title":"Cells"},{"issue":"10","key":"21_CR170","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.tins.2009.06.003","volume":"32","author":"D Eidelberg","year":"2009","unstructured":"Eidelberg D. Metabolic brain networks in neurodegenerative disorders: a functional imaging approach. Trends Neurosci. 2009;32(10):548\u201357.","journal-title":"Trends Neurosci"},{"issue":"5","key":"21_CR171","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/jcbfm.1994.99","volume":"14","author":"D Eidelberg","year":"1994","unstructured":"Eidelberg D, Moeller J, Dhawan V, Spetsieris P, Takikawa S, Ishikawa T, et al. The metabolic topography of parkinsonism. J Cereb Blood Flow Metab. 1994;14(5):783\u2013801.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"21_CR172","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.pbb.2007.05.002","volume":"87","author":"KL Eskow","year":"2007","unstructured":"Eskow KL, Gupta V, Alam S, Park JY, Bishop C. The partial 5-HT1A agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy. Pharmacol Biochem Behav. 2007;87(3):306\u201314.","journal-title":"Pharmacol Biochem Behav"},{"key":"21_CR173","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2021.118167","volume":"237","author":"XT Fang","year":"2021","unstructured":"Fang XT, Toyonaga T, Hillmer AT, Matuskey D, Holmes SE, Radhakrishnan R, et al. Identifying brain networks in synaptic density PET (11C-UCB-J) with independent component analysis. NeuroImage. 2021;237:118167.","journal-title":"NeuroImage"},{"issue":"348","key":"21_CR174","doi-asserted-by":"publisher","first-page":"348ra396-348ra3","DOI":"10.1126\/scitranslmed.aaf6667","volume":"8","author":"SJ Finnema","year":"2016","unstructured":"Finnema SJ, Nabulsi NB, Eid T, Detyniecki K, Lin S-F, Chen M-K, et al. Imaging synaptic density in the living human brain. Sci Transl Med. 2016;8(348):348ra396-348ra396.","journal-title":"Sci Transl Med"},{"issue":"2","key":"21_CR175","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","volume":"21","author":"A Gerhard","year":"2006","unstructured":"Gerhard A, Pavese N, Hotton G, Turkheimer F, Es M, Hammers A, et al. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson\u2019s disease. Neurobiol Dis. 2006;21(2):404\u201312.","journal-title":"Neurobiol Dis"},{"key":"21_CR176","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1146\/annurev-pharmtox-011613-135937","volume":"54","author":"SM Goldman","year":"2014","unstructured":"Goldman SM. Environmental toxins and Parkinson\u2019s disease. Annu Rev Pharmacol Toxicol. 2014;54:141\u201364.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"7","key":"21_CR177","first-page":"1275","volume":"36","author":"C Halldin","year":"1995","unstructured":"Halldin C, Farde L, H\u00f6gberg T, Mohell N, Hall H, Suhara T, et al. Carbon-11-FLB 457: a radioligand for extrastriatal D2 dopamine receptors. J Nucl Med. 1995;36(7):1275\u201381.","journal-title":"J Nucl Med"},{"issue":"3","key":"21_CR178","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1001\/archneur.62.3.378","volume":"62","author":"R Hilker","year":"2005","unstructured":"Hilker R, Schweitzer K, Coburger S, Ghaemi M, Weisenbach S, Jacobs AH, et al. Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity. Arch Neurol. 2005a;62(3):378\u201382. https:\/\/doi.org\/10.1001\/archneur.62.3.378.","journal-title":"Arch Neurol"},{"issue":"11","key":"21_CR179","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1212\/01.wnl.0000191154.78131.f6","volume":"65","author":"R Hilker","year":"2005","unstructured":"Hilker R, Thomas A, Klein J, Weisenbach S, Kalbe E, Burghaus L, et al. Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways. Neurology. 2005b;65(11):1716\u201322.","journal-title":"Neurology"},{"key":"21_CR180","doi-asserted-by":"publisher","first-page":"S210","DOI":"10.1016\/S1353-8020(11)70065-7","volume":"18","author":"EC Hirsch","year":"2012","unstructured":"Hirsch EC, Vyas S, Hunot S. Neuroinflammation in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2012;18:S210\u20132.","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"21_CR181","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1212\/WNL.0000000000000130","volume":"82","author":"F Holtbernd","year":"2014","unstructured":"Holtbernd F, Gagnon J-F, Postuma RB, Ma Y, Tang CC, Feigin A, et al. Abnormal metabolic network activity in REM sleep behavior disorder. Neurology. 2014;82(7):620\u20137.","journal-title":"Neurology"},{"issue":"9","key":"21_CR182","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1002\/hbm.22863","volume":"36","author":"F Holtbernd","year":"2015","unstructured":"Holtbernd F, Ma Y, Peng S, Schwartz F, Timmermann L, Kracht L, et al. Dopaminergic correlates of metabolic network activity in Parkinson\u2019s disease. Hum Brain Mapp. 2015;36(9):3575\u201385.","journal-title":"Hum Brain Mapp"},{"issue":"10","key":"21_CR183","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1093\/brain\/awaa238","volume":"143","author":"J Horsager","year":"2020","unstructured":"Horsager J, Andersen KB, Knudsen K, Skj\u00e6rb\u00e6k C, Fedorova TD, Okkels N, et al. Brain-first versus body-first Parkinson\u2019s disease: a multimodal imaging case-control study. Brain. 2020;143(10):3077\u201388. https:\/\/doi.org\/10.1093\/brain\/awaa238.","journal-title":"Brain"},{"key":"21_CR184","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1007\/s002590000365","volume":"27","author":"S Houle","year":"2000","unstructured":"Houle S, Ginovart N, Hussey D, Meyer J, Wilson A. Imaging the serotonin transporter with positron emission tomography: initial human studies with [11 C] DAPP and [11 C] DASB. Eur J Nucl Med. 2000;27:1719\u201322.","journal-title":"Eur J Nucl Med"},{"issue":"6","key":"21_CR185","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1001\/jamaneurol.2014.290","volume":"71","author":"T Hsiao","year":"2014","unstructured":"Hsiao T, Weng Y-H, Hsieh C-J, Lin W-Y, Wey S-P, Kung M-P, et al. Correlation of Parkinson disease severity and 18F-DTBZ positron emission tomography. JAMA Neurol. 2014;71(6):758\u201366.","journal-title":"JAMA Neurol"},{"issue":"2","key":"21_CR186","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.neuroimage.2006.09.003","volume":"34","author":"C Huang","year":"2007","unstructured":"Huang C, Mattis P, Tang C, Perrine K, Carbon M, Eidelberg D. Metabolic brain networks associated with cognitive function in Parkinson\u2019s disease. NeuroImage. 2007;34(2):714\u201323.","journal-title":"NeuroImage"},{"issue":"1","key":"21_CR187","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.parkreldis.2012.07.002","volume":"19","author":"S Iannaccone","year":"2013","unstructured":"Iannaccone S, Cerami C, Alessio M, Garibotto V, Panzacchi A, Olivieri S, et al. In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson\u2019s disease. Parkinsonism Relat Disord. 2013;19(1):47\u201352.","journal-title":"Parkinsonism Relat Disord"},{"key":"21_CR188","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","volume":"106","author":"K Imamura","year":"2003","unstructured":"Imamura K, Hishikawa N, Sawada M, Nagatsu T, Yoshida M, Hashizume Y. Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson\u2019s disease brains. Acta Neuropathol. 2003;106:518\u201326.","journal-title":"Acta Neuropathol"},{"issue":"11","key":"21_CR189","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/S1474-4422(10)70216-7","volume":"9","author":"A Iranzo","year":"2010","unstructured":"Iranzo A, Lome\u00f1a F, Stockner H, Valldeoriola F, Vilaseca I, Salamero M, et al. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. Lancet Neurol. 2010;9(11):1070\u20137. https:\/\/doi.org\/10.1016\/S1474-4422(10)70216-7.","journal-title":"Lancet Neurol"},{"issue":"15","key":"21_CR190","doi-asserted-by":"publisher","first-page":"e1605","DOI":"10.1212\/wnl.0000000000009246","volume":"94","author":"A Iranzo","year":"2020","unstructured":"Iranzo A, Stefani A, Ni\u00f1erola-Baizan A, Stokner H, Serradell M, Vilas D, et al. Left-hemispheric predominance of nigrostriatal deficit in isolated REM sleep behavior disorder. Neurology. 2020;94(15):e1605\u201313. https:\/\/doi.org\/10.1212\/wnl.0000000000009246.","journal-title":"Neurology"},{"key":"21_CR191","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13550-018-0450-0","volume":"8","author":"S Jakobson Mo","year":"2018","unstructured":"Jakobson Mo S, Axelsson J, Jonasson L, Larsson A, \u00d6gren MJ, \u00d6gren M, et al. Dopamine transporter imaging with [18 f] fe-pe2i pet and [123 i] fp-cit spect\u2014a clinical comparison. EJNMMI Res. 2018;8:1\u201313.","journal-title":"EJNMMI Res"},{"issue":"8","key":"21_CR192","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1001\/jamaneurol.2017.0985","volume":"74","author":"D Jennings","year":"2017","unstructured":"Jennings D, Siderowf A, Stern M, Seibyl J, Eberly S, Oakes D, et al. Conversion to Parkinson disease in the PARS hyposmic and dopamine transporter\u2013deficit prodromal cohort. JAMA Neurol. 2017;74(8):933\u201340. https:\/\/doi.org\/10.1001\/jamaneurol.2017.0985.","journal-title":"JAMA Neurol"},{"key":"21_CR193","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s00702-003-0816-x","volume":"110","author":"V Kaasinen","year":"2003","unstructured":"Kaasinen V, Aalto S, N\u00e5gren K, Hietala J, Sonninen P, Rinne J. Extrastriatal dopamine D 2 receptors in Parkinson\u2019s disease: a longitudinal study. J Neural Transm. 2003;110:591\u2013601.","journal-title":"J Neural Transm"},{"issue":"7","key":"21_CR194","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1212\/WNL.54.7.1482","volume":"54","author":"V Kaasinen","year":"2000","unstructured":"Kaasinen V, N\u00e5gren K, Hietala J, Oikonen V, Vilkman H, Farde L, et al. Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson\u2019s disease. Neurology. 2000;54(7):1482\u20137.","journal-title":"Neurology"},{"issue":"6","key":"21_CR195","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/ana.25103","volume":"82","author":"V Kaasinen","year":"2017","unstructured":"Kaasinen V, Vahlberg T. Striatal dopamine in P arkinson disease: a meta-analysis of imaging studies. Ann Neurol. 2017;82(6):873\u201382.","journal-title":"Ann Neurol"},{"issue":"8","key":"21_CR196","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1002\/mds.28632","volume":"36","author":"V Kaasinen","year":"2021","unstructured":"Kaasinen V, Vahlberg T, Stoessl AJ, Strafella AP, Antonini A. Dopamine receptors in Parkinson\u2019s disease: a meta-analysis of imaging studies. Mov Disord. 2021;36(8):1781\u201391. https:\/\/doi.org\/10.1002\/mds.28632.","journal-title":"Mov Disord"},{"key":"21_CR197","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2023.103347","volume":"37","author":"VS Kerstens","year":"2023","unstructured":"Kerstens VS, Fazio P, Sundgren M, Brumberg J, Halldin C, Svenningsson P, Varrone A. Longitudinal DAT changes measured with [18F]FE-PE2I PET in patients with Parkinson\u2019s disease; a validation study. NeuroImage Clin. 2023;37:103347. https:\/\/doi.org\/10.1016\/j.nicl.2023.103347.","journal-title":"NeuroImage Clin"},{"key":"21_CR198","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s40336-020-00386-w","volume":"8","author":"VS Kerstens","year":"2020","unstructured":"Kerstens VS, Varrone A. Dopamine transporter imaging in neurodegenerative movement disorders: PET vs. SPECT. Clin Transl Imaging. 2020;8:349\u201356.","journal-title":"Clin Transl Imaging"},{"issue":"7","key":"21_CR199","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/hbm.22006","volume":"34","author":"JH Ko","year":"2013","unstructured":"Ko JH, Antonelli F, Monchi O, Ray N, Rusjan P, Houle S, et al. Prefrontal dopaminergic receptor abnormalities and executive functions in Parkinson\u2019s disease. Hum Brain Mapp. 2013;34(7):1591\u2013604. https:\/\/doi.org\/10.1002\/hbm.22006.","journal-title":"Hum Brain Mapp"},{"issue":"2","key":"21_CR200","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1177\/0271678X16637880","volume":"37","author":"JH Ko","year":"2017","unstructured":"Ko JH, Lee CS, Eidelberg D. Metabolic network expression in parkinsonism: clinical and dopaminergic correlations. J Cereb Blood Flow Metab. 2017;37(2):683\u201393.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"9","key":"21_CR201","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138721","volume":"10","author":"Y Koshimori","year":"2015","unstructured":"Koshimori Y, Ko J-H, Mizrahi R, Rusjan P, Mabrouk R, Jacobs MF, et al. Imaging striatal microglial activation in patients with Parkinson\u2019s disease. PLoS One. 2015;10(9):e0138721.","journal-title":"PLoS One"},{"issue":"2","key":"21_CR202","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.neulet.2012.02.083","volume":"514","author":"V Kotagal","year":"2012","unstructured":"Kotagal V, M\u00fcller ML, Kaufer DI, Koeppe RA, Bohnen NI. Thalamic cholinergic innervation is spared in Alzheimer disease compared to parkinsonian disorders. Neurosci Lett. 2012;514(2):169\u201372.","journal-title":"Neurosci Lett"},{"issue":"11","key":"21_CR203","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/S1474-4422(20)30346-X","volume":"19","author":"WC Kreisl","year":"2020","unstructured":"Kreisl WC, Kim M-J, Coughlin JM, Henter ID, Owen DR, Innis RB. PET imaging of neuroinflammation in neurological disorders. Lancet Neurol. 2020;19(11):940\u201350. https:\/\/doi.org\/10.1016\/S1474-4422(20)30346-X.","journal-title":"Lancet Neurol"},{"key":"21_CR204","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.parkreldis.2020.11.011","volume":"82","author":"S Lavisse","year":"2021","unstructured":"Lavisse S, Goutal S, Wimberley C, Tonietto M, Bottlaender M, Gervais P, et al. Increased microglial activation in patients with Parkinson disease using [18F]-DPA714 TSPO PET imaging. Parkinsonism Relat Disord. 2021;82:29\u201336. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.11.011.","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"21_CR205","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4","volume":"47","author":"CS Lee","year":"2000","unstructured":"Lee CS, Samii A, Sossi V, Ruth TJ, Schulzer M, Holden JE, et al. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson\u2019s disease. Ann Neurol. 2000;47(4):493\u2013503.","journal-title":"Ann Neurol"},{"issue":"1","key":"21_CR206","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2967\/jnumed.113.121897","volume":"55","author":"SC Lin","year":"2014","unstructured":"Lin SC, Lin KJ, Hsiao IT, Hsieh CJ, Lin WY, Lu CS, et al. In vivo detection of monoaminergic degeneration in early Parkinson disease by (18)F-9-fluoropropyl-(+)-dihydrotetrabenzazine PET. J Nucl Med. 2014;55(1):73\u20139. https:\/\/doi.org\/10.2967\/jnumed.113.121897.","journal-title":"J Nucl Med"},{"issue":"4","key":"21_CR207","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1136\/jnnp-2012-303455","volume":"84","author":"C Marras","year":"2013","unstructured":"Marras C, Lang A. Parkinson\u2019s disease subtypes: lost in translation? J Neurol Neurosurg Psychiatry. 2013;84(4):409\u201315.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"21_CR208","doi-asserted-by":"publisher","unstructured":"Matuskey D, Tinaz S, Wilcox KC, Naganawa M, Toyonaga T, Dias M, et al. Synaptic changes in Parkinson\u2019s disease assessed with in-vivo imaging. Ann Neurol. 2020. https:\/\/doi.org\/10.1002\/ana.25682.","DOI":"10.1002\/ana.25682"},{"issue":"1","key":"21_CR209","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2967\/jnumed.116.183152","volume":"58","author":"SK Meles","year":"2017","unstructured":"Meles SK, Teune LK, de Jong BM, Dierckx RA, Leenders KL. Metabolic imaging in Parkinson disease. J Nucl Med. 2017;58(1):23\u20138. https:\/\/doi.org\/10.2967\/jnumed.116.183152.","journal-title":"J Nucl Med"},{"issue":"8","key":"21_CR210","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1001\/archgenpsychiatry.2009.106","volume":"66","author":"PM Meyer","year":"2009","unstructured":"Meyer PM, Strecker K, Kendziorra K, Becker G, Hesse S, Woelpl D, et al. Reduced \u03b14\u03b22*\u2013nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease. Arch Gen Psychiatry. 2009;66(8):866\u201377.","journal-title":"Arch Gen Psychiatry"},{"key":"21_CR211","doi-asserted-by":"publisher","unstructured":"Meyer PT, Frings L, R\u00fccker G, Hellwig S. 18F-FDG PET in parkinsonism: differential diagnosis and evaluation of cognitive impairment. J Nucl Med. 2017;58(12):1888\u201398. https:\/\/doi.org\/10.2967\/jnumed.116.186403.","DOI":"10.2967\/jnumed.116.186403"},{"issue":"6354","key":"21_CR212","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1126\/science.aaf3934","volume":"357","author":"S Mittal","year":"2017","unstructured":"Mittal S, Bj\u00f8rnevik K, Im DS, Flierl A, Dong X, Locascio JJ, et al. \u03b22-Adrenoreceptor is a regulator of the \u03b1-synuclein gene driving risk of Parkinson\u2019s disease. Science. 2017;357(6354):891\u20138.","journal-title":"Science"},{"key":"21_CR213","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1007\/s00259-020-04817-8","volume":"47","author":"S Morbelli","year":"2020","unstructured":"Morbelli S, Esposito G, Arbizu J, Barthel H, Boellaard R, Bohnen NI, et al. EANM practice guideline\/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0. Eur J Nucl Med Mol Imaging. 2020;47:1885\u2013912.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"21_CR214","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1136\/jnnp.64.3.314","volume":"64","author":"P Morrish","year":"1998","unstructured":"Morrish P, Rakshi J, Bailey D, Sawle G, Brooks D. Measuring the rate of progression and estimating the preclinical period of Parkinson\u2019s disease with [18F] dopa PET. J Neurol Neurosurg Psychiatry. 1998;64(3):314\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"21_CR215","doi-asserted-by":"publisher","first-page":"659","DOI":"10.2967\/jnumed.117.190975","volume":"59","author":"A Nahimi","year":"2018","unstructured":"Nahimi A, Sommerauer M, Kinnerup MB, \u00d8stergaard K, Winterdahl M, Jacobsen J, et al. Noradrenergic deficits in Parkinson disease imaged with (11)C-MeNER. J Nucl Med. 2018;59(4):659\u201364. https:\/\/doi.org\/10.2967\/jnumed.117.190975.","journal-title":"J Nucl Med"},{"issue":"12","key":"21_CR216","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres-Ciga S, Chang D, et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 2019;18(12):1091\u2013102.","journal-title":"Lancet Neurol"},{"issue":"11","key":"21_CR217","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1093\/brain\/awr233","volume":"134","author":"R Nandhagopal","year":"2011","unstructured":"Nandhagopal R, Kuramoto L, Schulzer M, Mak E, Cragg J, McKenzie J, et al. Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson\u2019s disease. Brain. 2011;134(11):3290\u20138.","journal-title":"Brain"},{"key":"21_CR218","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1007\/s00415-014-7302-2","volume":"261","author":"F Niccolini","year":"2014","unstructured":"Niccolini F, Su P, Politis M. Dopamine receptor mapping with PET imaging in Parkinson\u2019s disease. J Neurol. 2014;261:2251\u201363.","journal-title":"J Neurol"},{"issue":"5","key":"21_CR219","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/ana.23631","volume":"72","author":"M Niethammer","year":"2012","unstructured":"Niethammer M, Eidelberg D. Metabolic brain networks in translational neurology: concepts and applications. Ann Neurol. 2012;72(5):635\u201347.","journal-title":"Ann Neurol"},{"issue":"2","key":"21_CR220","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ana.20338","volume":"57","author":"Y Ouchi","year":"2005","unstructured":"Ouchi Y, Yoshikawa E, Sekine Y, Futatsubashi M, Kanno T, Ogusu T, Torizuka T. Microglial activation and dopamine terminal loss in early Parkinson\u2019s disease. Ann Neurol. 2005;57(2):168\u201375.","journal-title":"Ann Neurol"},{"issue":"2","key":"21_CR221","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/ana.24859","volume":"81","author":"G Pagano","year":"2017","unstructured":"Pagano G, Niccolini F, Fusar-Poli P, Politis M. Serotonin transporter in Parkinson\u2019s disease: a meta-analysis of positron emission tomography studies. Ann Neurol. 2017;81(2):171\u201380. https:\/\/doi.org\/10.1002\/ana.24859.","journal-title":"Ann Neurol"},{"key":"21_CR222","doi-asserted-by":"publisher","unstructured":"Paredes-Rodriguez E, Vegas-Suarez S, Morera-Herreras T, De Deurwaerdere P, Miguelez C. The noradrenergic system in Parkinson\u2019s disease. Front Pharmacol. 2020;11, 435. https:\/\/doi.org\/10.3389\/fphar.2020.00435.","DOI":"10.3389\/fphar.2020.00435"},{"issue":"3","key":"21_CR223","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1212\/wnl.0000000000002285","volume":"86","author":"DE Payer","year":"2016","unstructured":"Payer DE, Guttman M, Kish SJ, Tong J, Adams JR, Rusjan P, et al. D3 dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesia. Neurology. 2016;86(3):224\u201330. https:\/\/doi.org\/10.1212\/wnl.0000000000002285.","journal-title":"Neurology"},{"issue":"11","key":"21_CR224","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1002\/mds.10531","volume":"18","author":"W Pirker","year":"2003","unstructured":"Pirker W, Holler I, Gerschlager W, Asenbaum S, Zettinig G, Br\u00fccke T. Measuring the rate of progression of Parkinson\u2019s disease over a 5-year period with beta-CIT SPECT. Mov Disord. 2003;18(11):1266\u201372. https:\/\/doi.org\/10.1002\/mds.10531.","journal-title":"Mov Disord"},{"issue":"3","key":"21_CR225","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1172\/JCI71640","volume":"124","author":"M Politis","year":"2014","unstructured":"Politis M, Wu K, Loane C, Brooks DJ, Kiferle L, Turkheimer FE, et al. Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson\u2019s disease patients. J Clin Invest. 2014;124(3):1340\u20139. https:\/\/doi.org\/10.1172\/JCI71640.","journal-title":"J Clin Invest"},{"issue":"1","key":"21_CR226","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.nbd.2010.05.028","volume":"40","author":"M Politis","year":"2010","unstructured":"Politis M, Wu K, Loane C, Kiferle L, Molloy S, Brooks DJ, Piccini P. Staging of serotonergic dysfunction in Parkinson\u2019s disease: an in vivo 11C-DASB PET study. Neurobiol Dis. 2010a;40(1):216\u201321. https:\/\/doi.org\/10.1016\/j.nbd.2010.05.028.","journal-title":"Neurobiol Dis"},{"issue":"21","key":"21_CR227","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1212\/WNL.0b013e3181feb2ab","volume":"75","author":"M Politis","year":"2010","unstructured":"Politis M, Wu K, Loane C, Turkheimer F, Molloy S, Brooks D, Piccini P. Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures. Neurology. 2010b;75(21):1920\u20137.","journal-title":"Neurology"},{"issue":"9","key":"21_CR228","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1002\/syn.20658","volume":"63","author":"EA Rabiner","year":"2009","unstructured":"Rabiner EA, Slifstein M, Nobrega J, Plisson C, Huiban M, Raymond R, et al. In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: studies in non-human primates and transgenic mice. Synapse. 2009;63(9):782\u201393.","journal-title":"Synapse"},{"key":"21_CR229","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.nicl.2017.08.021","volume":"16","author":"A Rahmim","year":"2017","unstructured":"Rahmim A, Huang P, Shenkov N, Fotouhi S, Davoodi-Bojd E, Lu L, et al. Improved prediction of outcome in Parkinson\u2019s disease using radiomics analysis of longitudinal DAT SPECT images. NeuroImage Clin. 2017;16:539\u201344. https:\/\/doi.org\/10.1016\/j.nicl.2017.08.021.","journal-title":"NeuroImage Clin"},{"issue":"3","key":"21_CR230","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.nbd.2012.06.021","volume":"48","author":"NJ Ray","year":"2012","unstructured":"Ray NJ, Miyasaki JM, Zurowski M, Ko JH, Cho SS, Pellecchia G, et al. Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson\u2019s patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study. Neurobiol Dis. 2012;48(3):519\u201325. https:\/\/doi.org\/10.1016\/j.nbd.2012.06.021.","journal-title":"Neurobiol Dis"},{"issue":"4","key":"21_CR231","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1001\/archneur.59.4.580","volume":"59","author":"M-J Ribeiro","year":"2002","unstructured":"Ribeiro M-J, Vidailhet M, Loc\u2019h C, Dupel C, Nguyen JP, Ponchant M, et al. Dopaminergic function and dopamine transporter binding assessed with positron emission tomography in Parkinson disease. Arch Neurol. 2002;59(4):580\u20136.","journal-title":"Arch Neurol"},{"key":"21_CR232","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3233\/JPD-191710","volume":"10","author":"S Sakakibara","year":"2020","unstructured":"Sakakibara S, Hashimoto R, Katayama T, Kenjyo M, Yokokawa Y, Saito Y, et al. Longitudinal change of DAT SPECT in Parkinson\u2019s disease and multiple system atrophy. J Parkinsons Dis. 2020;10:123\u201330. https:\/\/doi.org\/10.3233\/JPD-191710.","journal-title":"J Parkinsons Dis"},{"issue":"3","key":"21_CR233","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0301-0082(96)00015-9","volume":"49","author":"RKW Schwarting","year":"1996","unstructured":"Schwarting RKW, Huston JP. Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae. Prog Neurobiol. 1996;49(3):215\u201366.","journal-title":"Prog Neurobiol"},{"issue":"4","key":"21_CR234","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1212\/WNL.0b013e3181ab2b58","volume":"73","author":"H Shimada","year":"2009","unstructured":"Shimada H, Hirano S, Shinotoh H, Aotsuka A, Sato K, Tanaka N, et al. Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET. Neurology. 2009;73(4):273\u20138. https:\/\/doi.org\/10.1212\/WNL.0b013e3181ab2b58.","journal-title":"Neurology"},{"issue":"5","key":"21_CR235","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/mds.27361","volume":"33","author":"T Simuni","year":"2018","unstructured":"Simuni T, Siderowf A, Lasch S, Coffey CS, Caspell-Garcia C, Jennings D, et al. Longitudinal change of clinical and biological measures in early Parkinson\u2019s disease: Parkinson\u2019s progression markers Initiative cohort. Mov Disord. 2018;33(5):771\u201382. https:\/\/doi.org\/10.1002\/mds.27361.","journal-title":"Mov Disord"},{"issue":"S6","key":"21_CR236","doi-asserted-by":"publisher","DOI":"10.1002\/alz.065394","volume":"18","author":"R Smith","year":"2022","unstructured":"Smith R, Capotosti F, Schain M, Ohlsson T, Touilloux T, Hliva V, et al. Initial clinical scans using [18F]ACI-12589, a novel \u03b1-synuclein PET-tracer. Alzheimers Dement. 2022;18(S6):e065394. https:\/\/doi.org\/10.1002\/alz.065394.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"21_CR237","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1093\/brain\/awx348","volume":"141","author":"M Sommerauer","year":"2017","unstructured":"Sommerauer M, Fedorova TD, Hansen AK, Knudsen K, Otto M, Jeppesen J, et al. Evaluation of the noradrenergic system in Parkinson\u2019s disease: an 11C-MeNER PET and neuromelanin MRI study. Brain. 2017;141(2):496\u2013504. https:\/\/doi.org\/10.1093\/brain\/awx348.","journal-title":"Brain"},{"issue":"6","key":"21_CR238","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1002\/mds.27411","volume":"33","author":"M Sommerauer","year":"2018","unstructured":"Sommerauer M, Hansen AK, Parbo P, Fedorova TD, Knudsen K, Frederiksen Y, et al. Decreased noradrenaline transporter density in the motor cortex of Parkinson\u2019s disease patients. Mov Disord. 2018b;33(6):1006\u201310. https:\/\/doi.org\/10.1002\/mds.27411.","journal-title":"Mov Disord"},{"issue":"2","key":"21_CR239","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/00004647-200202000-00011","volume":"22","author":"V Sossi","year":"2002","unstructured":"Sossi V, de La Fuente-Fern\u00e1ndez R, Holden JE, Doudet DJ, McKenzie J, Stoessl A, Ruth T. Increase in dopamine turnover occurs early in Parkinson\u2019s disease: evidence from a new modeling approach to PET 18F-fluorodopa data. J Cereb Blood Flow Metab. 2002;22(2):232\u20139.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"13","key":"21_CR240","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1523\/jneurosci.3082-17.2018","volume":"38","author":"AJ Stark","year":"2018","unstructured":"Stark AJ, Smith CT, Lin Y-C, Petersen KJ, Trujillo P, Wouwe NC v, et al. Nigrostriatal and mesolimbic D2\/3 receptor expression in Parkinson\u2019s disease patients with compulsive reward-driven behaviors. J Neurosci. 2018a;38(13):3230\u20139. https:\/\/doi.org\/10.1523\/jneurosci.3082-17.2018.","journal-title":"J Neurosci"},{"key":"21_CR241","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.nicl.2018.02.010","volume":"18","author":"AJ Stark","year":"2018","unstructured":"Stark AJ, Smith CT, Petersen KJ, Trujillo P, van Wouwe NC, Donahue MJ, et al. [18F]fallypride characterization of striatal and extrastriatal D2\/3 receptors in Parkinson\u2019s disease. NeuroImage Clin. 2018b;18:433\u201342. https:\/\/doi.org\/10.1016\/j.nicl.2018.02.010.","journal-title":"NeuroImage Clin"},{"key":"21_CR242","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3233\/JPD-191648","volume":"9","author":"D Stephenson","year":"2019","unstructured":"Stephenson D, Hill D, Cedarbaum JM, Tome M, Vamvakas S, Romero K, et al. The qualification of an enrichment biomarker for clinical trials targeting early stages of Parkinson\u2019s disease. J Parkinsons Dis. 2019;9:553\u201363. https:\/\/doi.org\/10.3233\/JPD-191648.","journal-title":"J Parkinsons Dis"},{"issue":"11","key":"21_CR243","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V. Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol. 2022;22(11):657\u201373. https:\/\/doi.org\/10.1038\/s41577-022-00684-6.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"21_CR244","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/mds.25361","volume":"28","author":"LK Teune","year":"2013","unstructured":"Teune LK, Renken RJ, Mudali D, De Jong BM, Dierckx RA, Roerdink JB, Leenders KL. Validation of parkinsonian disease-related metabolic brain patterns. Mov Disord. 2013;28(4):547\u201351.","journal-title":"Mov Disord"},{"issue":"11","key":"21_CR245","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1001\/archneur.61.11.1705","volume":"61","author":"S Thobois","year":"2004","unstructured":"Thobois S, Vingerhoets F, Fraix V, Xie-Brustolin J, Mollion H, Costes N, et al. Role of dopaminergic treatment in dopamine receptor down-regulation in advanced Parkinson disease: a positron emission tomographic study. Arch Neurol. 2004;61(11):1705\u20139.","journal-title":"Arch Neurol"},{"issue":"5","key":"21_CR246","first-page":"797","volume":"38","author":"T Vander Borght","year":"1997","unstructured":"Vander Borght T, Minoshima S, Giordani B, Foster NL, Frey KA, Berent S, et al. Cerebral metabolic difference s in Parkinson\u2019s and Alzheimer\u2019s disease s matched for dementia severity. J Nucl Med. 1997;38(5):797\u2013802.","journal-title":"J Nucl Med"},{"key":"21_CR247","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00259-018-4161-6","volume":"46","author":"K Varn\u00e4s","year":"2019","unstructured":"Varn\u00e4s K, Csel\u00e9nyi Z, Jucaite A, Halldin C, Svenningsson P, Farde L, Varrone A. PET imaging of [11 C] PBR28 in Parkinson\u2019s disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding. Eur J Nucl Med Mol Imaging. 2019;46:367\u201375.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"21_CR248","first-page":"68","volume":"56","author":"A Varrone","year":"2012","unstructured":"Varrone A, Halldin C. New developments of dopaminergic imaging in Parkinson\u2019s disease. Q J Nucl Med Mol Imaging. 2012;56(1):68\u201382.","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"2","key":"21_CR249","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/ana.10427","volume":"53","author":"AL Whone","year":"2003","unstructured":"Whone AL, Moore RY, Piccini PP, Brooks DJ. Plasticity of the nigropallidal pathway in Parkinson\u2019s disease. Ann Neurol. 2003;53(2):206\u201313. https:\/\/doi.org\/10.1002\/ana.10427.","journal-title":"Ann Neurol"},{"issue":"8","key":"21_CR250","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1002\/mds.28064","volume":"35","author":"H Wilson","year":"2020","unstructured":"Wilson H, Pagano G, de Natale ER, Mansur A, Caminiti SP, Polychronis S, et al. Mitochondrial complex 1, sigma 1, and synaptic vesicle 2A in early drug-naive Parkinson\u2019s disease. Mov Disord. 2020;35(8):1416\u201327.","journal-title":"Mov Disord"},{"issue":"6","key":"21_CR251","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.parkreldis.2013.02.013","volume":"19","author":"P Wu","year":"2013","unstructured":"Wu P, Wang J, Peng S, Ma Y, Zhang H, Guan Y, Zuo C. Metabolic brain network in the Chinese patients with Parkinson\u2019s disease based on 18F-FDG PET imaging. Parkinsonism Relat Disord. 2013;19(6):622\u20137.","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"21_CR252","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1093\/brain\/awu290","volume":"137","author":"P Wu","year":"2014","unstructured":"Wu P, Yu H, Peng S, Dauvilliers Y, Wang J, Ge J, et al. Consistent abnormalities in metabolic network activity in idiopathic rapid eye movement sleep behaviour disorder. Brain. 2014;137(12):3122\u20138.","journal-title":"Brain"},{"issue":"3","key":"21_CR253","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/cns.12493","volume":"22","author":"J Zou","year":"2016","unstructured":"Zou J, Weng R-H, Chen Z-Y, Wei X-B, Wang R, Chen D, et al. Position emission tomography\/single-photon emission tomography neuroimaging for detection of premotor Parkinson\u2019s disease. CNS Neurosci Ther. 2016;22(3):167\u201377. https:\/\/doi.org\/10.1111\/cns.12493.","journal-title":"CNS Neurosci Ther"}],"container-title":["Advances in Neurobiology","Neurophysiologic Biomarkers in Neuropsychiatric Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-69491-2_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T19:04:56Z","timestamp":1732043096000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-69491-2_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9783031694905","9783031694912"],"references-count":253,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-69491-2_21","relation":{},"ISSN":["2190-5215","2190-5223"],"issn-type":[{"value":"2190-5215","type":"print"},{"value":"2190-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"20 November 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}